THE HISTORY of MR. GLOBAL’S ATTACK on our FOOD SUPPLY

First of a four part series on the ongoing attack on the American Food Supply including a time line.

“In an effort to escape the continuous, racking abdominal cramping, Alex curled up into a fetal position and begged me to hold him. I stroked his face, attempting to calm him, to soothe him. I watched in horror his life hemorrhaging away in the hospital bathroom; bowl after bowl of blood and mucus gushed from his little body. Later, I helped change blood-soaked diapers that he had to wear after he could no longer stand or walk. Alex’s screams were followed by silence as the evil toxins attacked his brain causing him to lose neurological control. His eyes crossed and he suffered tremors and delusions. He no longer knew who I was.”
Nancy Donley, mother of Alex and President of Safe Tables Our Priority

The agonizing death of this little boy and many others WAS DELIBERATE. It was ‘JUST POLITICS.’ An orchestrated death, along with others, used to play up the need for legislation that moved control of the US food supply FROM AMERICAN’S INDEPENDENT FARMERS TO THE AG CARTEL OF THE WORLD TRADE ORGANIZATION.

Shielding the Giant USDA’s “Don’t Look, Don’t Know” Policy tells the tale of how the USDA ALLOWED ConAgra to Poison Americans with Tainted Meat to create a crisis to get their blasted Food Safety Modernization Act through Congress. For over a decade Congresswoman Rosa Delauro (D – CT) tried to get the food safety bill through congress with no luck. So they set-up a MAJOR food poisoning event the E. coli Outbreak at the 2004 North Carolina State Fair and the MSM blasted it all over the news. I give the insider details HERE . (Slight editing to make it more readable.)

…..I know Jason Wilke of Crossroads Farm Petting Zoo, the designated fall guy for the State Fair E. coli Outbreak in North Carolina (2004). It is curious that two weeks before there was NO outbreak at the Lee County fair where he was for a week and there was no outbreak the week after at another large venue. (I personally verified with the fair committee chairs.) However during the week he stayed home prepping for the state fair, an animal rights activist who was a USDA vet, stuck a thermometer up the butt of each of his animals thanks to that one line change in the Animal Welfare Act. She also told him she wanted to close him down. These actions and words were relayed to me via phone by Jason BEFORE the fair. (He wanted to vent and moan) … CDC did over 400 tests on Jason’s animals and the only vector route was through fresh feces. Skin/fur or mouth contact did not have viable organisms. Also it was the first case where this nasty strain of e coli showed up in sheep and goats. It was confined to concentrated feed lot operations prior to that. Operations that would be inspected by a USDA vet. The four year campaign by Animal Rights Activists in North Carolina to cause a bad accident/incident at pony rides or petting farms ended abruptly the week of the fair and has not resurfaced…. HMMMmmm.
Gail Combs

I did not mention in that comment that PETA targeted me, trying to arrange animal related injuries to children 4 times in the 6 months prior to the fair. The last attempt was less than a week before the fair. I have had no incidences since then. Also Feces SINK through the shavings so a child would literally have to go digging through the shavings for the fresh feces to eat. On the other hand State Fairs use casual labor (How many were PETA?) The food vendors would likely buy hamburger from the refrigerated trailers parked on the state grounds. The vendors equipment and area would be steam cleaned long before the inspectors would go looking for someone to pin the blame on. Therefore there would be zero chance of connecting the food vendors to the outbreak.

…What bothers me the most is that there is enough “leakage” to see the clear coordination. Like the “4 walling” of food related illnesses right up until the farm regulation bill was past. Now? Nothing. Well I’m sorry, but we did not overnight go to zero food poisoning or bacterial contamination. It just reeks of either deliberate contamination to create a panic or a deliberate propaganda effort coordinated from (somewhere) central.
It bothers me to think that the governments of the world are largely in the Railroading Business, but it is looking ever more that way. Clear lines of control, influence, action “for effect”, coordinated efforts agenda driven. I’d like to think we had a free association of people and a marketplace of ideas, evolving to the best ends. The evidence argues otherwise. The UN is clearly (and states so) acting as a central coordinating and influencing body. The intent to reduce the Nation State autonomy is also quite clear. (That the Big Players have publicly stated that intent makes it easier to see…
E.M. Smith (ChiefIO)

EM was certainly correct. Prior to that final incident in 2004 John Munsell tried to alert politicians and others. In a e-mail to me he even said he had a reporter stay with him for three days, write an article for a well know NY magazine, have it approved by the editor only to have the CEO kill the article at the last minute.

Meatpacking Maverick: John Munsell’s against-the-odds struggle for improved food safety — Mother Jones Magazine, December 2003 Issue

“Before the tainted beef arrived — USDA-approved and vacuum-sealed – Munsell had no reason to doubt the integrity of the food-safety system. But that changed after the meat he ground for hamburger tested positive for E. coli 0157:H7. Instead of tracking the contaminated meat back to its source, the USDA launched an investigation of Munsell’s own operation. Never mind that the local federal inspector had seen the beef go straight from the package into a clean grinder — a USDA spokesman called that testimony “hearsay.” By February 2002, three more tests of meat Munsell was grinding straight from the package came back positive. This time, as he would later testify in a government hearing, he had paperwork documenting that the beef came from a single source: ConAgra:

Munsell fired off an angry email to the district USDA manager, warning of a potential public-health emergency, and adding that if no one tracked down the rest of the bad meat, “both of us should share a cell in Alcatraz.” The agency moved immediately and aggressively — not to recall meat from Greeley, but to shut down Munsell’s grinding operation, a punishment that lasted four months. Despite Munsell’s continued whistleblowing — to Senator Conrad Burns (R-Mont.), national cattle associations, and his fellow meat processors — the USDA failed to address the alleged contamination at ConAgra’s Greely Plant. Then, in July 2002, Munsell’s worst fears came true. E. coli-tainted burger from Greeley killed an Ohio woman and sickened at least 35 others. ConAgra then recalled 19 million pounds of beef, one of the largest recalls in history.”
Michael Scherer, Mother Jones Magazine

John Munsell even contacted a lawyer, Bill Marler, a products liability attorney. One E. coli O157:H7 Outbreak I Think I could have prevented

But again nothing was done. The switch from the ‘safest food in the world’ to feces laced hamburger can be traced to the switch from hands on USDA food inspection to HACCP, a new system where inspectors no longer inspect FOOD, they inspect PAPERWORK. John Munsell does a great job of explaining the change in:

HACCP’S Disconnect From Public Health Concerns (PLEASE READ)

An amusing short article on the harassment John had to put up with from the USDA: Five Minutes With John Munsell & A Trip To The Woodshed With The USDA

Unfortunately there are just too of many “incidents” that have been handled in such a way that transnational corporations are not “inconvenienced”. Stanley Painter, Chairman of the National Food Inspection Unions, stated in his testimony at the congressional hearing on the Hallmark Dower Cows:

“..when we see violations of FSIS regulations,.. we are instructed not to write non-compliance reports… Sometimes even if we write non-compliance reports, some of the larger companies use their political muscle to get those overturned….Some of my members have been intimidated by agency management in the past when they came forward and tried to enforce agency regulations and policies. I will give you a personal example: [SRM removal regulations concern brain and spine removal to prevent BSE] …
In December 2004, I began to receive reports that the new SRM regulations were not being uniformly enforced. I wrote a letter to the Assistant FSIS Administrator for Field Operations at the time conveying to him what I had heard…I was paid a visit at my home in Alabama by an FSIS official dispatched from the Atlanta regional office to convince me to drop the issue. I told him that I would not.
Then, the agency summoned me to come here to Washington, DC where agency officials subjected me to several hours of interrogation including wanting me to identify which of my members were blowing the whistle on the SRM removal violations. I refused to do so….I was then placed on disciplinary investigation status. The agency even contacted the USDA Office of Inspector General to explore criminal charges being filed against me…
Both my union AFGE and the consumer group Public Citizen filed separate Freedom of Information Act requests in December 2004 for any non-compliance records in the FSIS data base…. It was not until August 2005 that over 1000 non-compliance reports – weighing some 16 pounds — were turned over to both AFGE and Public Citizen that proved that what my members were telling me was correct – that some beef slaughter facilities were not complying with the SRM removal regulations… on the same day those records were released, I received written notification from the agency that they were dropping their disciplinary investigation – eight months after their “investigation” began.
Stanley Painter

When the act failed to pass under the sponsorship of Democrat Rosa Delauno, the Act was then CO-SPONSORED by Senator Burr (R – NC) I go through some of the ramifications of that law HERE. The KEY is the Ag Cartel controlled World trade Organization would determine the rules US farmers would have to live by.

SEC. 404. COMPLIANCE WITH INTERNATIONAL AGREEMENTS.
Nothing in this Act (or an amendment made by this Act) shall be construed in a manner inconsistent with the agreement establishing the World Trade Organization or any other treaty or international agreement to which the United States is a party.

Sir Julian Rose talks of the ramifications fo the OIE & FAO recommendations worldwide in The Battle to Save the Polish Countryside

….Spend hours out of your working day filling in endless forms, filing maps and measuring every last inch of your fields, tracks and farmsteads; applying for ‘passports’ for your cattle and ear tags for your sheep and pigs; re-siting the slurry pit and putting stainless steel and washable tiles on the dairy walls; becoming versed in HASAP hygiene and sanitary rules and applying them where any food processing was to take place; and living under the threat of convictions and fines should one put a finger out of place or be late in supplying some official details…
Sir Julian Rose

Do not forget that Bush signed a treaty to HARMONIZE US laws with that of the EU.

“In a sweeping move that has garnered surprisingly little attention this week the United States and the European Union have signed up to a new transatlantic economic partnership that will see regulatory standards “harmonized” and will lay the basis for a merging of the US and EU into one single market, a huge step on the path to a new globalized world order.” The BBC reported from the Summit in Washington on Monday….
http://stopspp.com/stopspp/?p=122 (Defunct URL)

And the FDA in 2003 even had up on their website: International Harmonization

The harmonization of laws, regulations and standards between and among trading partners requires intense, complex, time-consuming negotiations by CFSAN officials. Harmonization must simultaneously facilitate international trade and promote mutual understanding, while protecting national interests and establish a basis to resolve food issues on sound scientific evidence in an objective atmosphere. Failure to reach a consistent, harmonized set of laws, regulations and standards within the freetrade agreements and the World Trade Organization Agreements can result in considerable economic repercussions.
FDA

The international Ag Cartel was the driving force behind the Agreement on Agriculture, HACCP and the doubling of Food Borne illnesses. I did the graphs for a presentation before congress showing the five years before HACCP and the five years after. The USDA responded just as the DOD is now. ‘OH the first five years didn’t capture ALL the food borne illness. We switched to a different system where the reports (MANDATORY BY LAW) can be emailed instead of Faxed or sent by mail.’

This doubling of food borne illness, well hyped by the media, was used to justify the new law, the Food Safety Modernization Act, REGULATING farming (not the corporate processing plants.) These new regulations are meant to be used to kill off US independent farmers.

Again the USDA and the FDA LIED. They stated there had been no up date to our food safety system AFTER they had already implemented HACCP allowing the Ag cartel to inspect themselves.

In September, 1995, USDA’s Food Safety & Inspection Service presented a 600-page document Farm-To-Table – control of every step in the food chain from production to home preparation.

Reshaping USDA’s Meat & Poultry Inspection Program . . . An AAMP Perspective & Analysis Of The Agency’s Top-To-Bottom Review And How It Affects You And Your Business by Steve Krut, American Association of Meat Processors

For plants with more than one process (meaning more than one HACCP program), verification activities would be scheduled to ensure that all HACCP plans are covered at least once a month. Compliance over time would mean less frequent verification.
Some key steps:
Verification – Inspector checks to see that the plant is doing what is in its process control or HACCP plan. This may last several hours or perhaps one day.
Validation – FSIS evaluates the plant’s HACCP plan to be certain it is appropriate and works for the product and process covered. A target frequency for validation audit would be at least once every two years for every HACCP plan. This is likely to involve an FSIS out-of-plant technical person or team and take several days to a week, but will occur on site…
Steve Krut, American Association of Meat Processors

The Grain Trader Dan Amstutz, Who wrote the Draft of the WTO Agreement on Agriculture was VP of Cargill (grain) and then moved to Goldman Sachs (How Goldman Sachs Created the Food Crisis- with it’s entry into the commodities market) He originally worked in the department of Ag under Reagan but his draft Agreement on Ag and Draft farm bill was passed under Clinton.

Background from 1945: History, HACCP and the Food Safety Con Job

The author Nicole Johnson takes us through how a Milner Round Table, the Committee for Economic Development (CED), intentionally changed the US agriculture system from a decentralized system to the vertically integrated system favored by the Ag cartel.

The human cost of CED’s plans were exacting and enormous.

CED’s plans resulted in widespread social upheaval throughout rural America, ripping apart the fabric of its society destroying its local economies. They also resulted in a massive migration to larger cities. The loss of a farm also means the loss of identity, and many farmers’ lives ended in suicide.
CED members were influential in business, government, and agricultural colleges, and their outlook shaped both governmental policies and what farmers were taught. Farmers found themselves encouraged to give up on a farming system that employed minimal outsourced inputs and capital and get “efficient” by adopting instead a system that required they go into debt in order to purchase ever more costly inputs, like fossil-fuel based fertilizers, chemicals, seeds, feed grain, and machinery. The local, decentralized food distribution networks that were previously in place became subject to corporate buyouts, vertical integration and consolidation, leaving farmers with fewer and fewer outlets to sell their goods.
With this consolidation of grain handlers, railways, food processing, meat packing, brewing and beverage makers, cereal makers, food retailers and restaurants, more and more of the food dollar went to processors and retailers, which gained increased market power. Farmers, meanwhile, were and continue to be squeezed on both ends: by input suppliers putting upward pressure on selling prices and by output buyers exerting downward pressure on their buying prices.
This analysis is confirmed by the Keystone Center, an establishment think tank with representatives on its board from Monsanto, DuPont, Shell, Coca-Cola, Dow, General Electric and the Rockefeller Foundation, to name a few. The organization’s 2001 report “The Keystone National Policy Dialogue on Trends in Agriculture” observes that “Agricultural policy in many respects supported the concentration of farming into larger and fewer units. Some would say agricultural policy is biased toward bigness.”

Home Gardens ARE covered in case you are wondering..

“..FOOD PRODUCTION FACILITY- The term ‘food production facility’ means any farm, ranch, orchard, vineyard, aquaculture facility, or confined animal-feeding operation…”

There is NO exemption for instate commerce, for hobby farms, for you backyard garden.

“ The Administrator, in order to protect the public health, shall establish a national traceability system that enables the Administrator to retrieve the history, use, and location of an article of food through all stages of its production, processing, and distribution.
set good practice standards to protect the public and animal health and promote food safety;

conduct monitoring and surveillance of animals, plants, products, or the environment, as appropriate

require each food production facility to have a written food safety plan that describes the likely hazards and preventive controls implemented to address those hazards;

include, with respect to growing, harvesting, sorting, and storage operations, minimum standards related to fertilizer use, nutrients, hygiene, packaging, temperature controls, animal encroachment, and water”

Notice it does not say a person SELLING food, it says a person holds, stores, or transports food or food ingredients. This is very scary given Ag Sec. Venman’s ” September, 1995, USDA’s Food Safety & Inspection Service presented a 600-page document Farm-To-Table – control of every step in the food chain from production to home preparation. “

Also included is this.
“in any action to enforce the requirements of the food safety law, the connection with interstate commerce required for jurisdiction SHALL BE PRESUMED TO EXIST.”
The fact you are growing veggies for you and friends does not exclude you!

SEE: Overlawyered — H.R. 875, Food Safety Modernization Act of 2009 by WALTER OLSON and Trojan Horse Law: The Food Safety Modernization Act of 2009 by Hans Bader

….Lori Robertson of FactCheck.org, who is not a lawyer (she has a B.A. in advertising), claims the bill doesn’t apply to “that tomato plant in your backyard.” As a lawyer, I am skeptical of this claim (I co-represented the prevailing defendant in the last successful constitutional challenge to federal regulation under the interstate commerce clause…
….Ignorance about the law’s broad reach (and how it will be construed by the courts) has thwarted opposition to the bill, which will likely pass Congress. For example, a newspaper claims the bill “doesn’t regulate home gardens.” The newspaper probably assumed that was true because the bill, like most federal laws, only purports to reach activities that affect “interstate commerce.” To an uninformed layperson or journalist, that “sounds as if it might not reach local and mom-and-pop operators at all.” (The bill’s sponsor, Rep. Rosa DeLauro, has sought to forestall opposition to her bill by falsely claiming that that “the Constitution’s commerce clause prevents the federal government from regulating commerce that doesn’t cross state lines.”)
But lawyers familiar with our capricious legal system know better. The Supreme Court ruled in Wickard v. Filburn (1942) that even home gardens (in that case, a farmer’s growing wheat for his own consumption) are subject to federal laws that regulate interstate commerce. Economists and scholars have criticized this decision, but it continues to be cited and followed in Supreme Court rulings, such as those applying federal anti-drug laws to consumption of even home-grown medical marijuana. Indeed, many court decisions allow Congress to define as “interstate commerce” even non-commercial conduct that doesn’t cross state lines — something directly at odds with Rep. DeLauro’s claims.
Hans Bader

DEAR KAG: 20220225 – The Pub is OPEN / COVID-19 Vaccine Interference With AIDS and Syphilis Tests / Moscow Mule Revisited / Failure of Socialized Science and Peer Review Exposed in a JAMA-Published Ivermectin Study

The Pub is OPEN!

And we’re finally serving a NORMAL DRINK tonight. Even though it’s a SECOND ROUND.

STAY TUNED…..

While our beloved REAL bartender takes a needed break of unknown duration, we continue to ENDEAVOR TO PERSEVERE.

and what time of year is it now???

Christmas Spirit

We continue our WAAAAAY too-long celebration of Christmas by noting that some of our neighbors STILL have their lights and decorations up.

We saw a nice red Christmas bow laying in somebody’s yard by their driveway.

We ourselves just got rid of our tree.

And TODAY is the 25th of the month. That’s VERY “Christmassy”.

So yeah. Given that there are a few ~~days~~ ~~weeks~~ months AFTER Christmas where it’s STILL Christmas, that means we have a few more weeks left. Riiiiiiight?

Sure! So have some hot CHRISTMAS chocolate!

And now, the rules of the pub.

HOUSE RULES

God bless us, every one! Tiny Tim had such a beautiful soul. He hadn’t a mean bone in his body…unlike most of us. But in keeping with Christmas, we promise to honor Wolf’s rules and keep Scrooge at bay. The Utree is where the Ghost of Christmas Present will conduct you should you need to rattle some chains. Another option, should all hell break loose is here.

Now, back to business.

AMEN!

Free the January Brothers!

Current Art On The Wall

We’re just gonna segue into the next item with our selection, if that’s OK.

This gets a bit “planetary”…..

**Christiaan Huygens, Saturn, and Something**

https://owlcation.com/stem/Huygens-Mission-on-Titan

**LINK: https://www.instagram.com/p/BAOVsasAXhl/**

**Mercury**, the old cure for ***grandgore***.

COVID-19 Vaccine Interference With AIDS and Syphilis Tests

Earlier this week, RAC brought a news item from CTH, which really got me thinking:

FDA Warns of Vaccine Induced Positive Syphilis Test

This had to do with a CDC alert…..

LINK: https://www.cdc.gov/std/FDA-alert-12-20-2021.pdf

…..which was based off of an FDA alert (sketchy link)…..

…..which actually links back to a different CDC alert (even sketchier link)…..

WHATEVER.

Here is that final CDC alert. Only the top 3 paragraphs are important here.

Let me quote the text of those first 3 paragraphs for Zoe. I will make BOLD what is important.

Dear Partners in Prevention,

December 20, 2021

I’m writing to share the U.S. Food and Drug Administration (FDA) alert sent to clinical laboratory staff and health care providers about a syphilis test. The alert reports that false reactivity, or “false-positive,” Rapid Plasma Reagin (RPR; non-treponemal) test results, when using the Bio-Rad Laboratories BioPlex 2200 Syphilis Total & RPR kit, can occur in some people who received a COVID-19 vaccine and includes recommendations for addressing these potential false positives.

Historically, false-reactive RPR test results have been observed in people with systemic infections unrelated to syphilis, such as tuberculosis, rickettsial diseases, and endocarditis. False-reactive RPR testing also has been previously observed following immunization (specifically following smallpox vaccine). False reactivity with RPR can also occur during pregnancy.

Per CDC’s 2021 STI Treatment Guidelines, reactive RPR results should always be confirmed with treponemal testing (e.g., Treponema pallidum particle agglutination, TP-PA). This is, in part, because of the above-mentioned issue: false-positive nontreponemal test results can be associated with multiple medical conditions and factors unrelated to syphilis. According to FDA’s alert, treponemal testing for syphilis does not appear to be impacted by this issue.

Allow me to translate.

It turns out that “being vaccinated for COVID-19” throws off an ANTIBODY-BASED SYPHILIS TEST, and can give false positives.

The reason is that these are a sort of antibodies against substances released from cells attacked by certain diseases and conditions. Thus, they’re not exclusively the downstream product of syphilis.

Normally, certain diseases, certain vaccines, and pregnancy can all throw off this more rapid but less conclusive syphilis test, and that is part of the reason why people are supposed to follow up this easier test, with a test that looks for the actual organism which causes syphilis.

Thus, we have added one more cause for the test to be thrown off.

This is not the same as the HIV test that was thrown off by a particular Australian vaccine, because the antigen in the vaccine actually contained an HIV protein (gp41) as part of the vaccine, and created antibodies against HIV. I talked about that last week. That was a much more direct test interference, easily expected.

Saved From The Frankenvax

How a Psycho Vaccine Marrying the Infamous COVID Spike Protein to HIV’s Neurotoxic gp41 Was [Allegedly] Canned by a Mere Testing SNAFU How Australia Dodged The First Mad Vax Bullet of the WEF Scamdemic / Plannedemic Darwin Award Vaccine Featured Insane Merger of HIV and COVID But Failed Due to Buggering of AIDS Tests, NOT …

What I find interesting is that one of the things that normally sets off the syphilis test is endocarditis.

Endocarditis, which is inflammation of the inner surfaces of the heart, is one of the three main heart inflammations, thus being pretty damned close to myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer sac), both of which have very prominent correlations to the jabs.

So while this means that – NO – the shots are not giving people syphilis – the shots ARE basically acting like an illness, and very much like a known cardiac illness.

You were warned.

Now – while I was researching syphilis, I became interested in the treatment with compounds of mercury.

Traditional mercury-based pastes were used in cures. Whilst this was partially effective, the toxic side effects of the mercury probably outweighed any advantages.

This is actually a HUGE understatement.

It turned out that arsenic was considerably better.

The first effective treatment for syphilis was arsphenamine, discovered by Sahachiro Hata in 1909, during a survey of hundreds of newly synthesized organic arsenical compounds led by Paul Ehrlich. It was manufactured and marketed from 1910 under the trade name Salvarsan by Hoechst AG.^[88] This organoarsenic compound was the first modern chemotherapeutic agent.

It wasn’t too long after that success, that penicillin took over as the real cure for syphilis.

I will come back to MERCURY in a future post, because I found something quite amazing in its history.

But if you look ONE COLUMN TO THE LEFT and TWO ROWS UP…..

COPPER is also bacteriostatic and algicidal – and at concentrations below where it is a health risk. And THAT leads back to a DRINK that Grandmaintexas introduced us to……

Moscow Mule Revisited

Based upon my reading of Grandma’s post on the subject, the Moscow Mule simply is not a proper Moscow Mule unless it is served in copper vessels.

The health effects of COPPER are about as debatable as the effects of mercury – although, in general, copper is much less toxic, so when it’s being “not good for you”, it’s a lot less “not good for you” than lead. At the same time, copper is much MORE toxic to things like algae, fungi, plant roots, and other “pests”, than it is to us, and that is why it is found among the gardening pesticides in hardware stores. The antimicrobial activity of copper is extremely well-documented, but appears to be complex. Simply having copper in the household or workplace environment seems to have health benefits – and this was particularly noted back in the days of less sanitary environments. Water passing through copper fixtures tended not to spread disease.

We tend to forget about OLD SCIENCE, so we can’t put new things into good perspective.

LEAD and other CHEMICAL ADVANCES saved us from the horrible BIOLOGICAL diseases and maladies of the uncivilized life.

Did they have chemical consequences? Yes. The TRICK is REMEMBERING AND ADMITTING OLD RISKS AND BENEFITS while also DISCOVERING AND ADMITTING NEW RISKS AND BENEFITS, then BALANCING HONESTLY with the PROPER PRIORITIES which put PEOPLE FIRST.

It is VERY easy to see where CDC went off the rails with the COVID-19 vaccines, being unable to admit old benefits (of lasting immunity to caught and treated diseases), while also being unable to admit new risks (of vaccines using untested and immature technologies).

Likewise, looking back, it is easy to see that basic sanitation – not vaccination – REALLY conquered diseases. Vaccines came in, mopped up, and took all the credit, by design, because bad people realized that vaccines in the hands of a technological elite, combined with an ignorant populace they can essentially murder and experiment on at will, allow them to basically FARM HUMANITY.

Sorry, Bill Gates. We understand your social engineering of us. We know your M.O. We know your real intentions. Including for the “people of color” you pretend to care about.

You will note that, in general, the further down the periodic table one goes, the more toxic the metals. Surprisingly, the second-lightest one – beryllium – is quite toxic, but even lightweight aluminum simply isn’t all that bad, in the big picture (but you’ve got to keep it on the OUTSIDE). In contrast, if you get down and heavy there with mercury, thallium and lead, or even as far down the table as cadmium and indium, the metals can be quite toxic.

Lead used to be used for plumbing – enough to lend its name to the profession. Copper then took over – before plastic began to displace copper. Nevertheless, copper is still highly valued for plumbing, as well as for electrical wiring.

As noted above, copper in drinking water is an interesting beast. Lead and copper in drinking water are controlled by the EPA under something called the Lead and Copper Rule, or LCR. Note that the linked document, which talks about the most recent “upgrade” to the rule, is over 400 pages. Yeah – there is a MESS of goofiness outside the actual rule there. Most of the concern is about lead, which is now highly restricted. Here is all that is said about copper’s toxicity in the linked explainer:

Acute copper exposure causes gastrointestinal distress. Chronic exposure to copper is particularly a concern for people with Wilson’s disease because they are prone to copper accumulation in body tissue, which can lead to liver damage, neurological, and/or psychiatric symptoms. For a more detailed explanation of the health effects associated with copper see Appendix E of the final rule Economic Analysis (USEPA, 2020). EPA did not propose revisions to the copper requirements; thus, the final rule does not revise the copper requirements.

Copper is basically off the hook at 1.3 ppm or below. That number has not been upgraded. Why is that level important? In my opinion, it’s because copper is bacteriostatic and algicidal in practice at between 0.1 and 1.0 ppm. Thus, one can SAFELY DRINK water which is being purified against microorganisms with copper.

And THAT would include the Moscow Mule, depending upon how long it sits.

I refer you now to an excellent article, which relies on a breathless scaremongering headline, but actually DOES provide a balanced set of viewpoints on both the DANGERS and BENEFITS of dietary copper.

Sipping This Popular Cocktail Is a “Health Hazard,” Experts Say

AFTER 27 MINUTES, YOU MAY BE AT RISK OF HEAVY METAL POISONING.

LINK: https://bestlifeonline.com/moscow-mule-copper-news/

ARCHIVE: https://archive.fo/6YT3X

First of all, copper isn’t really a “heavy metal” IMO, but whatever. It’s heavier than some.

You will note, after reading at the link, that you have to drink a ton of Moscow Mules, or a few that have sat around for a very long time, to MAYBE get sickened by them.

In general, avoid drinking acidic things that have been in contact with copper for a long time, and you will be OK.

Remember – most household water has sat around in copper pipes for quite a while at neutral pH, and it’s simply not toxic (due to copper). You DO get less lead if you flush your water 30 seconds before getting drinking water, but again – we’re talking about levels that would make Romans, Victorians, and even people from 70 years ago howl with laughter at our prissy over-concern – even knowing the science.

Perspective is very important – as you are about to see in a beautiful example of the failure of modern science, thanks to CCP socialism infecting both global science and science publishing.

Failure of Socialized Science and Peer Review Exposed in a JAMA-Published Ivermectin Study

The fact that Pierre Kory now calls JAMA “PHAMA” is a nice short way of saying that medicine has been utterly taken over by the pharmaceutical industry, and IMO set back several thousand years. Hippocrates would be HORRIFIED by what has happened to medicine – and I say that as somebody OUTSIDE medicine, and a lot closer to the pharmaceutical industry.

IMO it’s too late to save the pharmaceutical industry from scandalous criminal survival – but it’s not too late to save the profession of medicine from utter moral death. And thus, you will be treated to my following scientific opinion.

Steve Kirsch doesn’t play defense. He saw how JAMA (the Journal of the American Medical Association) completely FUMBLED an ivermectin paper, and how Pierre Kory picked it up off the ground, taking complete control, but more or less just standing there, lamenting the bad refs and horrible cheating. So Kirsch did the only thing he does. He grabbed the ball from Kory and ran it back for a touchdown.

“New JAMA paper show Ivermectin blows the COVID vaccines out of the water”

This is an utter reversal of the conclusion of the paper.

All because some guy in the stands named “Massimaux” spotted the free ball and yelled “FUMBLE!!!”

If you understand science, and science publishing, then you will see that what Kirsch did here was BRUTAL. And I’m gonna show you where all the bruises and black eyes are.

I almost feel sorry for JAMA, but not enough to miss this opportunity to LEAP ONTO THE DOGPILE and give AMA’s hare-brained PC leadership a good WEDGIE.

Don’t worry about the AMA. They’re protected by Pfizer, Biden, and the media. And just like any good mafia arrangement, as long as AMA keeps saying the right things, and not saying the wrong things, everything is gonna be OK.

Everything but science. But that’s OK, too.

We’ll take care of things. Just like we did here.

Here is the Kirsch gab that grabbed my attention.

Repeating for Zoe, as well as our silicon friends…..

Steve Kirsch
@stkirsch
22h·

New JAMA paper show Ivermectin blows the COVID vaccines out of the water

https://stevekirsch.substack.com/p/new-jama-paper-show-ivermectin-blows?r=o7iqo&utm_campaign=post&utm_medium=web

New JAMA paper show Ivermectin blows the COVID vaccines out of the water

Whoops! How embarrassing! The CDC gave you bad advice. If you want to survive COVID, you should use the drug they said to avoid, and avoid the drug they said to…

stevekirsch.substack.com

View Link Feed

2,589 likes
208 comments
1,670 reposts
42 quotes

Now, as soon as I saw this, I was going….

“Wait a second. I thought there was some paper just out that Alex Berenson said was basically the end of ivermectin, although scientifically, I know that’s pretty much impossible. I know there is SOME explanation for why this paper (which I have not read yet) has to be deviating in some way from the MANY papers that show limited but solid efficacy – and especially against DEATH – just like HCQ. But this CANNOT be the same paper. No way! Kirsch would not be saying this unless the results were stunningly IN FAVOR of ivermectin, and there is no WAY that some authors with a NEGATIVE-LEANING study would be……. I mean….. WHAT THE HELL????”

SO – I just stopped to see what in the hell paper Kirsch was talking about.

YUP.

This is the SAME PAPER.

ARTICLE: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362

SUPPLEMENTARY: https://cdn.jamanetwork.com/ama/content_public/journal/intemed/0/ioi220006supp2_prod_1644957301.65433.pdf

This is the SAME PAPER that caused Alex Berenson to issue TWO articles:

Ivermectin fails

To the ivermectin fanatics

Now we’ve discussed (in the comments on this site) Berenson’s very weird attack on Robert Malone when they appeared together on Fox News, which didn’t make sense THEN, but which does NOW – and I will explain that momentarily. But first, back to Kirsch.

Kirsch explains that – YES – this paper states in BOTH its abstract and its conclusion the following:

“The study findings do not support the use of ivermectin for patients with COVID-19.”

However, that is NOT what the data says.

Certainly not to everybody.

Certainly not to me.

In other words, DIFFERENT scientists (like Kirsch, Kory, me, and an anonymous Twitter poster names Massimaux, who found the key issue) have looked at the data, and see something quite different.

Kory goes into a rather long analysis of the whole war against ivermectin, but Kirsch digs into Kory’s article and then finds and elucidates the key nugget – discovered by Massimaux – that just ends the arguments.

It helps to read this in Kirsch’s article, but if you’re going to be lazy, I’ll explain here.

Here is Massimaux’s tweet:

In the I-TECH study, of 490 patients, 241 got Ivermectin and 331 were vaccinated.

Can we compute the vaccine effectiveness AGAINST DEATH and Ivermectin effectiveness AGAINST DEATH? Yes, we can! See the figure.

Which prevented more deaths, The Vaccine or Ivermectin? pic.twitter.com/WszQMQkAYX
— Massimaux (@masimaux) February 20, 2022

Look at the bottom line in the two tables and compare. Not only is ivermectin CLEARLY better than the vaccine at preventing death – the significance of the result is significantly greater.

If the efficacy of ivermectin against death is not true, then very little else in the study is true.

This data says that ivermectin is exactly what we’ve been saying it is. It’s not a miracle cure, but it WORKS – particularly in preventing DEATH – its only real purpose. That result is IN THE PAPER. It is IN THE DATA. And if the authors want to argue that it’s not in the data, because it’s not significant enough, then nothing ELSE is in the data, because most everything else is even LESS significant.

Now it’s very important to realize that this nice little pair of tables FROM THE DATA is not due to the original authors – it’s due to a POST-PUBLICATION “peer review” by somebody who looked at the very same data, and PROVED using the authors’ own data that they were WRONG to say that the data didn’t support use of ivermectin.

So why did the authors tack on that wrong statement?

Did the EDITORS make them tack on that statement?
Did the AUTHORS tack it on to get the paper to publish?
Or is the “peer bias” against ivermectin, mostly due to the media, SO STRONG that scientists didn’t even look through their own data to see a conclusion they didn’t want to see?

Or is it a combination of ALL of these?

It is clearly in the data that ivermectin is three times as effective as the vaccines in preventing death. Even more importantly, if you add in what is known OUTSIDE the paper in question – namely the adverse effects of the vaccine and the safety of ivermectin, then it’s a no-brainer to NOT take the vaccine and to just use ivermectin. And Kirsch explains THAT rather nicely.

The data LITERALLY justify our position.

This was my hunch all along, and as vaccine side effects loomed larger and larger, and ivermectin proved to be rather shockingly harmless, even at antiviral doses comparable to large-animal systemic antiparasitic doses. All ivermectin had to do was prevent death to some moderate extent, and it was a no-brainer that people should take it.

To conclude anything else, based on the data, is murderous folly, in my opinion.

When I was a young lad – a mere student – but also one who WROTE PAPERS (because I had a great professor who TRAINED US to be full-blooded scientists), we EXPECTED to be CRITICIZED in peer review by people exactly like Steve Kirsch, Pierre Kory, and myself. We expected that others would look at data and see it completely differently.

And we would then have to ACKNOWLEDGE the alternative interpretations, or convince the editors that the criticism was not even worth acknowledging (a VERY rare occurrence in any legitimately contested field).

My lab had PRACTICE criticizing other people’s work – and we expected it in return. I personally found quite a few errors in the literature. Most were small – mostly problems of the writing – but some were huge and affected the science. Sometimes the big errors would only partially alter the author’s conclusions, but other times they had a significant impact.

However, I have to admit that I never ran into data which PROVED THE OPPOSITE of the authors’ main conclusion – even if only to the critic – and THAT is what we have here.

PEER REVIEW is designed to subject a paper to (hopefully at least TWO) critical readers who will very likely DEMAND improvements. Those improvements often mean acknowledging DIFFERENT views of the data as being possible and maybe even reasonable.

That kind of QUALITY peer review was VERY OBVIOUSLY not done here.

What we have RIGHT HERE is a demonstration that HERD REVIEW is much more important than PEER REVIEW.

PEER REVIEW is subject to BIAS. It is subject to SUBVERSION and GAMING.

I go back to the Zhang mask paper, for crying out loud.

To me, this will always remain a horrifying example of “fitting the data to the theory”, rather than looking to see what the data says. You can just look at this graph and see the crime.

I lay this stuff SQUARELY at the feet of SOCIALISM, which has politicized science and removed control of science from the people of science themselves, investing much of it in a media which WILL NOT question government narratives. People raised under socialism who become “go-alongers” – and so SOME degree that is everybody – stop questioning things that need to be questioned.

I have WATCHED and I have SEEN how WEF and CCP corruption have degraded science everywhere.

They’re not going to fix this stuff – at least not yet.

But until then, know this:

Ivermectin WORKS, and it was just proven by people who said it doesn’t work.

Thanks to HERD REVIEW.

One last point.

Why did Alex Berenson not see this?

IMO, it’s because Berenson is simply not a scientist – he’s an investigative journalist. Thus, his virtue-signaling attack on Malone was meant to show “journalistic balance”, NOT that he himself had deeply researched the history of the topic, in which case he (Berenson) would have likely said “Yes, Malone really is the most foundational of the founding fathers of the tech.”

But let’s not blame Alex too hard. THE AUTHORS OF THIS STUDY – that’s right – the authors themselves – didn’t see it, either.

See what I’ve always said? Real science is contentious.

But it has a good heart.

It wants the TRUTH.

ENJOY THE SHOW.

Thank you all for being here. Have a great weekend.

W

The Nuremberg Code vs US Law and The Push For World Government

TradeBait2 Made the comment:

I have been reminding folks on here – the Fed has to be bankrupted at some point. It will either be by the white hats or the black hats. The Gab post you show is correct for the most part IMO. The Fed has fueled the Great Reset, which is why they could care less about how much debt we have in America because we will not exist as an independent nation in their black hat world.
Digital one world currency is the plan. Why do you think there were coin shortages recently? Why do you think they hate crypto and parallel economies so much? Why do they want America at odds with Russia, but falling right in line with China? Where Xi falls in this I am not certain. But I do know China and the Chi-coms are a CB [central bank] creation.
The linchpin is digital currency.
Follow the money….

That is the first half of the comment

Actually I can see where he is going since I also have warned of this much earlier.

The Push For World Government

A few years ago Soros directed the USA to overthrow the ELECTED government in both Syria and Ukraine. (Trump side stepped both.)

Why? Because the EU is the model for a global government. Soros wanted the EU to annex the Ukraine. The elected president said HE!! NO! so he was ousted and a pro-EU puppet was put in his place who has since been voted out while Trump was in the White House.

Russia tossed Soros out and put out a warrant for him. Russia makes much of their money selling gas to Europe. It also gives them leverage to keep the EU from expanding into their sphere of influence. Soros wants to remove Russia’s leverage by putting in a pipeline from the middle east to Europe. ALL the countries that were opposed to that pipeline have been overthrown EXCEPT for Syria.

If you want a World Government similar to the European Union then you are on Soros side. If you want sovereign nations you are on the side of Russia….. AND I am still of that opinion.

BREXIT THE MOVIE will give you the details on how the EU is actually run.

https://www.youtube.com/watch?v=UTMxfAkxfQ0

Former World Trade Organization Director-General Pascal Lamy tells you point blank that the EU is the template for the desired World Government and it has been the plan since the 1930s.

All had lived through the chaos of the 1930s — when turning inwards led to economic depression, nationalism and war. All, including the defeated powers, agreed that the road to peace lay with building a new international order — and an approach to international relations that questioned the Westphalian, sacrosanct principle of sovereignty…
Pascal Lamy, Whither Globalization

Lamy is quite blunt in stating national sovereignty is passé:

…more than half a century ago that the Frenchman Jean Monnet, one of the shapers of post-war Europe, said, “The sovereign nations of the past can no longer provide a framework for the resolution of our present problems. And the European Community itself is no more than a step towards the organizational forms of tomorrow’s world.” His assessment was as valid then as it is now….
Pascal Lamy, Global Governance: Lessons from Europe

Lamy indicates that a super state fashioned after the European Union is the goal and he calls for European-Inspired Global Governance:

This is what Global Warming was really about. We have all seen the political message morph over the decades from Global Warming to Climate Change to Weather Weirding.

As H.L. Mencken said:

“The whole aim of practical politics is to keep the populace alarmed — and hence clamorous to be led to safety — by menacing it with an endless series of hobgoblins, all of them imaginary.”

In other words, create a crisis to order to implement Diocletian’s Problem-Reaction-Solution

Mencken also warns:

“The urge to save humanity is almost always only a false face for the urge to rule it.”

The UN put the concept into practice via the IPCC. The IPCC mandate states:

The Intergovernmental Panel on Climate Change (IPCC) was established by the United Nations Environmental Programme (UNEP) and the World Meteorological Organization (WMO) in 1988 to assess the scientific, technical and socio-economic information relevant for the understanding of human induced climate change, its potential impacts and options for mitigation and adaptation. http//www.ipcc-wg2.gov/ (No longer available)
IPCC

Notice the IPCC ASSUMES the hypothesis of human induced climate change IS TRUE and goes from there.

With Reagan killing off the Cold War, Pascal Lamy takes ‘Practical Politics’ the next step, by telling us about a “new enemy to unite us” (Global Warming) A global enemy needed to create Legitimacy, one of the ‘four legs’ needed to implement a global government…

I see four main challenges for global governance today.
The first one is leadership, i.e. the capacity to embody a vision and inspire action, in order to create momentum. Who is the leader? Should it be a superpower? A group of national leaders? Selected by whom? Or should it be an international organization?
The second one is efficiency, i.e. the capacity to mobilize resources, to solve the problems in the international sphere, to bring about concrete and visible results for the benefit of the people. The main challenge here is that the Westphalian order gives a premium to “naysayers” who can block decisions, thereby impeding results. The ensuing viscosity of international decision-making puts into question the efficiency of the international system.
The third one is coherence, for the international system is based on specialization. Each international organization focuses on a limited number of issues. The World Trade Organisation deals with trade, the International Labour Organisation with labour issues, the World Meteorological Organisation with meteorology and so the list continues. It is a fact: the UN is not really overarching, assuming this was the initial intention.
The last challenge that I see is that of legitimacy— for legitimacy is intrinsically linked to proximity, to a sense of “togetherness”. By togetherness, I mean the shared feeling of belonging to a community. This feeling, which is generally strong at the local level, tends to weaken significantly as distance to power systems grows. It finds its roots in common myths, a common history, and a collective cultural heritage. It is no surprise that taxation and redistribution policies remain mostly local!
There is one place where attempts to deal with these challenges have been made and where new forms of governance have been tested for the last 60 years: in Europe. The European construction is the most ambitious experiment in supranational governance ever attempted up to now. It is the story of a desired, delineated and organized interdependence between its Member States…. http://www.wto.org/english/news_e/sppl_e/sppl220_e.htm
Pascal Lamy

In another presentation Lamy again addresses the problem of legitimacy:

It gives me great pleasure to be here today to participate in this thematic debate on the United Nations in global governance, an issue of the utmost importance given the urgency of the global challenges we are facing… As for legitimacy, I see two avenues to strengthen it. First, domestically, by increasing the visibility of international issues and giving citizens a greater say…. https://archive.globalpolicy.org/social-and-economic-policy/the-three-sisters-and-other-institutions/global-governance-and-the-three-sisters-1-11/50398-lamy-urges-raising-un-ecosoc-profile.html%3Fitemid=id.html
Pascal Lamy

By now, with Al Gore exiting stage left, Trump entering stage right, it is pretty obvious that ‘Global Warming’ has lost its high panic factor and the climb down is in progress. However the need for a ‘Crisis to Unite Us’ and a reason to implement ‘Agenda 21 – Sustainability’ and ‘Global Governance’ still remains. WORSE for the Globalists the fiat currency central banking system is on its last legs and about to IMPLODE, as many people like Dave of the X22 Report and Clif High and others have been warning us. Up to now we have been wondering what the next hobgoblin would be. And now we know it’s COVID -19!!! A Bio-Weapon and a Poison Jab that kills off a lot of the population, crashes the world economy and ushers in a Vaccine Digital Passport soon to be linked to the BRAND NEW DIGITAL WORLD CURRENCY and Social Credit Score.

And that brings us to the second part of TradeBait2’s comment.

…… You do not want to use the Nuremberg Code as your get out jail free card from jabs. You fall into the hands of international law superseding national law. It’s a set up, don’t fall for it.
Cannot tell you the number of times I have prepared a post and deleted it because I doubted folks on here would pay attention or believe it. This is the world I lived in for 35 years and escaped.

As I showed above that “international law superseding national law” is exactly what Pascal Lamy was yammering about a decade ago and what Klaus Schwab is threatening us with now.

So how do we escape this TRAP if it is being set?

Use USA LAW!

I find it interesting that the internet is FULL of the Nuremberg Code…….

……and the GERMAN/CALIFORNIA LAWYER Reiner Füllmich and 50 Lawyers, but I went nutz trying to find the US LAWS. It took me over ½ hour.

And WHY does Reiner Füllmich have no problem with YouTube???? When everyone else gets the boot?

https://duckduckgo.com/?q=Reiner+F%C3%BCllmich+youtube&t=brave&ia=videos&iax=videos

JW in Germany even brought us this comment:

I watched it for about half an hour and thought it was important enough to post here. The dozens of witnesses/experts that will be speaking in the next days are from around the world…many of the names you may already know.
Day 1 Opening Session of the Grand Jury Proceeding
A group of international lawyers and a judge are conducting criminal investigation modeled after Grand Jury proceedings in order to present to the public all available evidence of Covid 19 Crimes Against Humanity to date against “leaders, organizers, instigators, and accomplices” who aided, abetted, or actively participated in the formulation and execution of a common plan for a pandemic
https://gettr.com/post/psoiulc122

Those are things that make you go HMMMmmm…..

I think Reiner Füllmich and his group is sincere but it is very very possible they are being used.

So after a LOT of digging at Cornell Law I found the provision that covers the situation for the military: 10 U.S.C. § 1107. “This provision prohibits the administration of investigational new drugs, or drugs unapproved for their intended use, to service members without their informed consent.”

And finally after a lot more searching I stumbled across the information that civilians are covered under a FDA Regulation and not a law:
CFR – Code of Federal Regulations Title 21 as of January 6, 2022

Subpart B – Informed Consent of Human Subjects
   § 50.20 – General requirements for informed consent.
   § 50.23 – Exception from general requirements.
   § 50.24 – Exception from informed consent requirements for emergency research.
   § 50.25 – Elements of informed consent.
   § 50.27 – Documentation of informed consent.

[Code of Federal Regulations]
[Title 21, Volume 1]
[CITE: 21CFR50.20]

TITLE 21–FOOD AND DRUGS
CHAPTER I–FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES

SUBCHAPTER A – GENERAL
PART 50 — PROTECTION OF HUMAN SUBJECTS
Subpart B – Informed Consent of Human Subjects
Sec. 50.20 General requirements for informed consent.
Except as provided in §§ 50.23 and 50.24, no investigator may involve a human being as a subject in research covered by these regulations unless the investigator has obtained the legally effective informed consent of the subject or the subject’s legally authorized representative. An investigator shall seek such consent only under circumstances that provide the prospective subject or the representative sufficient opportunity to consider whether or not to participate and that minimize the possibility of coercion or undue influence. The information that is given to the subject or the representative shall be in language understandable to the subject or the representative. No informed consent, whether oral or written, may include any exculpatory language through which the subject or the representative is made to waive or appear to waive any of the subject’s legal rights, or releases or appears to release the investigator, the sponsor, the institution, or its agents from liability for negligence.
[46 FR 8951, Jan. 27, 1981, as amended at 64 FR 10942, Mar. 8, 1999]

BUT there is a cockroach in the ointment.

§ 50.24 – Exception from informed consent requirements for emergency research.

[Code of Federal Regulations]
[Title 21, Volume 1]
[CITE: 21CFR50.24]

TITLE 21–FOOD AND DRUGS
CHAPTER I–FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES

SUBCHAPTER A – GENERAL
PART 50 — PROTECTION OF HUMAN SUBJECTS
Subpart B – Informed Consent of Human Subjects
Sec. 50.24 Exception from informed consent requirements for emergency research.
(a) The IRB responsible for the review, approval, and continuing review of the clinical investigation described in this section may approve that investigation without requiring that informed consent of all research subjects be obtained if the IRB (with the concurrence of a licensed physician who is a member of or consultant to the IRB and who is not otherwise participating in the clinical investigation) finds and documents each of the following:
(1) The human subjects are in a life-threatening situation, available treatments are unproven or unsatisfactory, and the collection of valid scientific evidence, which may include evidence obtained through randomized placebo-controlled investigations, is necessary to determine the safety and effectiveness of particular interventions.
(2) Obtaining informed consent is not feasible because:
(i) The subjects will not be able to give their informed consent as a result of their medical condition;
(ii) The intervention under investigation must be administered before consent from the subjects’ legally authorized representatives is feasible; and
(iii) There is no reasonable way to identify prospectively the individuals likely to become eligible for participation in the clinical investigation.
(3) Participation in the research holds out the prospect of direct benefit to the subjects because:
(i) Subjects are facing a life-threatening situation that necessitates intervention;
(ii) Appropriate animal and other preclinical studies have been conducted, and the information derived from those studies and related evidence support the potential for the intervention to provide a direct benefit to the individual subjects; and
(iii) Risks associated with the investigation are reasonable in relation to what is known about the medical condition of the potential class of subjects, the risks and benefits of standard therapy, if any, and what is known about the risks and benefits of the proposed intervention or activity.
(4) The clinical investigation could not practicably be carried out without the waiver.
(5) The proposed investigational plan defines the length of the potential therapeutic window based on scientific evidence, and the investigator has committed to attempting to contact a legally authorized representative for each subject within that window of time and, if feasible, to asking the legally authorized representative contacted for consent within that window rather than proceeding without consent. The investigator will summarize efforts made to contact legally authorized representatives and make this information available to the IRB at the time of continuing review.
(6) The IRB has reviewed and approved informed consent procedures and an informed consent document consistent with § 50.25. These procedures and the informed consent document are to be used with subjects or their legally authorized representatives in situations where use of such procedures and documents is feasible. The IRB has reviewed and approved procedures and information to be used when providing an opportunity for a family member to object to a subject’s participation in the clinical investigation consistent with paragraph (a)(7)(v) of this section.
(7) Additional protections of the rights and welfare of the subjects will be provided, including, at least:
(i) Consultation (including, where appropriate, consultation carried out by the IRB) with representatives of the communities in which the clinical investigation will be conducted and from which the subjects will be drawn;
(ii) Public disclosure to the communities in which the clinical investigation will be conducted and from which the subjects will be drawn, prior to initiation of the clinical investigation, of plans for the investigation and its risks and expected benefits;
(iii) Public disclosure of sufficient information following completion of the clinical investigation to apprise the community and researchers of the study, including the demographic characteristics of the research population, and its results;
(iv) Establishment of an independent data monitoring committee to exercise oversight of the clinical investigation; and
(v) If obtaining informed consent is not feasible and a legally authorized representative is not reasonably available, the investigator has committed, if feasible, to attempting to contact within the therapeutic window the subject’s family member who is not a legally authorized representative, and asking whether he or she objects to the subject’s participation in the clinical investigation. The investigator will summarize efforts made to contact family members and make this information available to the IRB at the time of continuing review.
(b) The IRB is responsible for ensuring that procedures are in place to inform, at the earliest feasible opportunity, each subject, or if the subject remains incapacitated, a legally authorized representative of the subject, or if such a representative is not reasonably available, a family member, of the subject’s inclusion in the clinical investigation, the details of the investigation and other information contained in the informed consent document. The IRB shall also ensure that there is a procedure to inform the subject, or if the subject remains incapacitated, a legally authorized representative of the subject, or if such a representative is not reasonably available, a family member, that he or she may discontinue the subject’s participation at any time without penalty or loss of benefits to which the subject is otherwise entitled. If a legally authorized representative or family member is told about the clinical investigation and the subject’s condition improves, the subject is also to be informed as soon as feasible. If a subject is entered into a clinical investigation with waived consent and the subject dies before a legally authorized representative or family member can be contacted, information about the clinical investigation is to be provided to the subject’s legally authorized representative or family member, if feasible.
(c) The IRB determinations required by paragraph (a) of this section and the documentation required by paragraph (e) of this section are to be retained by the IRB for at least 3 years after completion of the clinical investigation, and the records shall be accessible for inspection and copying by FDA in accordance with § 56.115(b) of this chapter.
(d) Protocols involving an exception to the informed consent requirement under this section must be performed under a separate investigational new drug application (IND) or investigational device exemption (IDE) that clearly identifies such protocols as protocols that may include subjects who are unable to consent. The submission of those protocols in a separate IND/IDE is required even if an IND for the same drug product or an IDE for the same device already exists. Applications for investigations under this section may not be submitted as amendments under §§ 312.30 or 812.35 of this chapter.
(e) If an IRB determines that it cannot approve a clinical investigation because the investigation does not meet the criteria in the exception provided under paragraph (a) of this section or because of other relevant ethical concerns, the IRB must document its findings and provide these findings promptly in writing to the clinical investigator and to the sponsor of the clinical investigation. The sponsor of the clinical investigation must promptly disclose this information to FDA and to the sponsor’s clinical investigators who are participating or are asked to participate in this or a substantially equivalent clinical investigation of the sponsor, and to other IRB’s that have been, or are, asked to review this or a substantially equivalent investigation by that sponsor.
[61 FR 51528, Oct. 2, 1996]

And now we go to USA lawyer, Attorney Thomas Renz and his interview on Bannon’s War Room.

Episode 1,619 – Beijing Olympics Fail; Legal/Financial Investigations Of Big Pharma

https://rumble.com/vu5amo-episode-1619-beijing-olympics-fail-legalfinancial-investigations-of-big-pha.html

ROUGH TRANSCRIPT (start at 18:15)

ATTORNEY THOMAS RENZ: We have to get it to the public and that is where the War room is so important.
Se are going to be submitting this to a case in Alabama. We are going to be submitting ths to a number of different places in the military, ahhh I guess law enforcement world. And we are looking to bring this into the civilian law enforcement as well. There is no question as to what is happening. These are major crimes and you know Steve, I don’t know if you have got this but we just yesterday, dated February 4th, got a document from the CDC that re-affirms everything we said last week when we said they know this. If you are interested that document actually says it is was in the meeting yesterday, it was presented yesterday it says the CDC is working to monitor these things and they are monitoring the DOD data. Which indicates to me, I don’t know if you have heard the DOD s response? DOD to me has committed fraud and conspiracy. They have said there baseline data from 2016 to 2020 was wrong. They didn’t notice it until we pointed it out in the whistle blower testimony. But some how even though they didn’t notice it, it magically got corrected in 2021.

I mean seriously, How stupid do they think the American people are?

STEVE BANNON: What about adjudicating this. What about Alabama? (21:40)

RENZ: We have a case in Alabama where we are challenged the EUA authorization of the vaccine….. Balance of harm tests…. Generally you have to show more benefit than injury… we are also challenging on mis branding, because the CDC changed the definition of vaccines so they could call these gene therapies a vaccine. BTW Pfizer and Moderna have admitted they are gene therapy in their documents. And we have challenged it on several other fronts so that’s in court. This document and all this DOD stuff just came to us. We have declarations under penalty of perjury and those declarations will be submitted to the court. They are getting updated right now because we’ve had this new data come forward related to this…. We have been working with attorneys all over the world and around the country… and we have been getting this data out and we are giving it to anyone who wants to use it anywhere they can. And we believe it will help. We have to find the right court like you said. Until we find a court that is willing to listen and have an evidentiary hearing, it’s tough. We are going to have more info on that coming up…..

STEVE: asks about military JAG system and Senator Johnson. Senator Johnson first.

RENZ: The problem for Senator Johnson is he is not getting enough support from other Senators. He has gotten NO RESPONSE from anyone else [including Rand Paul but he does not say that.]

STEVE: What about JAG? [24:50]

RENZ: Since the data has only been out for a week or two, we are working thru a number of JAG officers….. I got another letter this week…. From all places the Texas National Guard, one of the people there saying they are going to reject all the religious exemptions and we don’t want doctors giving medical exemptions. They actually say they view it as a COMMAND ISSUE and not a medical issue. So if a doctor thinks a soldier should not have this for a medical reason, they are to shut-up and take orders according to this document. We submitted that to Senator Johnson as well as some others.

This is a disaster in the military and they have created a situation where it is very very difficult for our solders to fight this. We do however have quite a number of military personnel stepping forward. And quite a number of JAG officers and others who, because of the publicity we have gotten on this, in the last week or so, are now wiling to step up and do something so we’ll see.

It goes on to Edward Dowd about the insurance industry data about unexpected deaths in working age people from there. Steve Bannon mentions that Zero Hedge covered the information given too. Suicide? How Some Life Insurance Companies Are Dealing With Experimental Vaccines Deaths

A very informative earlier video from the War Room showing the DOD changing the data from Thomas Renz. It also has Ed Dowd, a Financial guru who worked for Blackrock…. Yeah, Blackrock. He is calling out not only the vaccine manufacturers but the FDA for massive FINANCIAL fraud similar to ENRON. The video also has an interview with Dr Malone.

From 27:00 to 35:15 minutes

https://rumble.com/vtkou8-episode-1602-the-big-short-pfizer-and-moderna-the-new-enron-are-criminal-ch.html

-GC

Big Pharma – Government – University Collusion on COVID Vaccines

Newly Uncovered COVID Vaccine Contracts Lead Unexpectedly to Academic Corruption and Shill Science Attacks on Honest, Skeptical Scientists

A Gail Combs deep dive into a tangent of Karen Kingston’s latest revelation on Pfizer Comirnaty vaccine deaths and injuries, leads back to the war against truth-telling doctors and scientists – this time by their own CORRUPT university employers.

PREFACE by Wolf Moon

Remember people saying that there was no such thing as the “FDA-approved” Comirnaty version of the Pfizer vaccine in existence?

Well, it turns out that REAL, LIVE COMIRNATY is out there, it has already killed over 50 people [in VAERS – yeah – do the math – x20 (1000), x40 (2000), or x100 (5000)], and – now even more shocking – there was some kind of bureaucratic screw-up in the contract and approval process which makes Pfizer LIABLE for all the deaths and injuries.

Look – I don’t know about the latter part – that’s “the law”, which is basically filled with LIES at this point. Whether any of these people will ever answer for anything is highly debatable, in my opinion.

But that’s not where this goes.

Gail Combs started looking at this video, and discovered ANOTHER scandal – the fact that universities which are silencing and firing honest doctors and scientists are not doing so from some misperception or moral high ground. These universities are turning on honest doctors and scientists because the universities themselves are COMPROMISED – by money, corruption, and the involvement of OTHER scientists at those same universities in the “scamdemic”.

We don’t yet know how deep this goes, but we do know this – the universities are clearly in cover-up mode. It’s not just limited to the vaccines. Fauci’s horrifying executioner remdesivir was forwarded past Trump, thanks to “work” done at one such university.

Follow along with Gail and you’ll see the SHAME of what has happened to many American universities, once bastions of free thinking and HONESTY – now CORRUPT and enemies of TRUTH.

-Wolf

START HERE….

FDA Broke Pfizer’s EUA Shield: Liability Protection Gone, Time To Bring Down The Gavel (10 minutes)

Stew Peters Show, Published January 26, 2022

LINK: https://www.redvoicemedia.com/2022/01/fda-broke-pfizers-eua-shield-liability-protection-gone-time-to-bring-down-the-gavel/

LINK: https://rumble.com/vtcugv-fda-broke-pfizers-eua-shield-liability-protection-gone-time-to-bring-down-t.html

Stew Peters interviews former Pfizer employee and analyst Karen Kingston, who does deep dives into patents and contracts. She found the three major contracts for Moderna, J&J and Pfizer.

Stew: “Karen says she found contracts showing the DOD was in control of what data went to the FDA from vaccine trials. If that is true, then DOD not Big Pharm, was the central figure in any vaccine cover-up…. Military leaders maybe exposed as well…. When the FDA approved the Pfizer vax under the name Cormirnaty, it somehow broke their immunity shield.”

That is not exactly correct. DOD delegated it to Pfizer. With the Pfizer contract with the US Army, it appears that, it was delegated to Pfizer to have the ability to manipulate the data that was submitted to the FDA.

With the Moderna contract for example it shows HHS [US Dept of Health & Human Services] had the authority to manipulate the data that was submitted to the FDA. The contract date is 4/03/2020 for ½ billion $$$ with NIH subsidizing a lot of the contract. It was for producing 100 million mRNA vaccines. The contract (shown) states:

* Contractor shall submit draft FDA submission to BARDA at least 15 days prior to FDA submission
* BARDA will provide feedback to Contractor within 10 days of receipts
* The Contractor MUST address, in writing its consideration of all concerns raised by BARDA prior to FDA Submission.

NOTICE THE DATE 4/03/202. No wonder they wanted to kill HCQ in April!

April 7, 2020 Trump’s Critics Attack His Optimistic Case for Hydroxychloroquine

Karen goes on to say that the contract says that BARDA can provide EDITS to the Data and THAT gets submitted to the FDA. She has never seen anything like this before. This [editing] is why the data was so phenomenally positive. This explains why the Whistle Blowers at Ron Johnson’s Formun found the DOD data had been ‘edited’ to remove the tons of adverse events.

She also said a lot of that contract is redacted including the Key personnel at BARDA .

The J&J contract of an mRNA vaccine was signed 08-Apr-2015 and 60 out of the 90 pages are redacted.

She then goes into the most recent contract. It is a joint mission of Dept of Defense and Dept of Health & Human services who contract with Pfizer/BoiNTech “for the co-development and distribution (excluding China) of a potential mRNA-based Coronavirus vaccine aimed at preventing Covid-19 infection“….. LOTS OF REDACTION….

The Research Collaboration & License Agreement
by and between
PFIZER INC.
and
BIONTECH RNA PHARMACEUTICALS GmbH [Germany]
and
BIOTECH AG
July 20, 2018

Again the DATE July 20 2018 shows mRNA vaccines for the next outbreak of Covid WAS A DONE DEAL!

@5:00 Karen EXPLAINS the OOPS in the Contract. You can not have a contract for commercialization WITHOUT A FDA APPROVAL DATE!!! So how in Hades did they KNOW there would be FDA APPROVAL? This shows it was PRE-PLANNED IN 2018.

@7:00 She also found the Cormirnaty lots used in the USA and the VAERs data

LOT NUMBERS
FD7220
FE3592
FF2587
FF2588
FF2590
FF2593
FF8841
VAERS Dec 2021
Deaths = 51
Disabilities = 94
Hospitalizations 415

So who is BARDA?

Biomedical Advanced Research and Development Authority (BARDA)

WE ARE BARDA
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.
Together with our industry partners, BARDA promotes the advanced development of medical countermeasures to protect Americans and respond to 21st century health security threats.

About NIH | National Institutes of Health (NIH)
A part of the U.S. Department of Health and Human Services, NIH is the largest biomedical research agency in the world

So there is your Fauci connection.

And that brings me to the digging I have been doing.

I start with the Chair of the COVID VACCINE ADVISORY BOARD, Hana El Sahly, M.D. of Baylor College of Medicine. She is the one who wrote the Remdesivir paper for Fauci, just in the nick of time so he could get that toxin approved for the use in hospitalized elderly Covid patients.

Baylor College rang a major bell with me. This Yahoo News articles shows why:

August 2, 2021

Dr. Peter McCullough Sued by Baylor After Appearance on Stew Peters Show…

Dr. Peter McCullough is being sued by the healthcare system that just mandated 40,000 employees to get the jab, and they’re doing it out of spite. Here’s the list of emails to those targeting him, if you wish to let them know how you feel….

Sidebar by Wolf – Dr. McCullough on Stew Peters

I dare anybody to watch this and find anything wrong with anything that Peter McCullough is saying. He is basically admitting – at a time when social media was still removing people for saying as much – that the vaccines seemed to no longer be working. And NOW we know why – because of the delta variant.

LINK: https://www.redvoicemedia.com/2021/08/stew-peters-show-dr-peter-mccullough-destroys-vaxx-efficacy-narrative-united-pilots-file-suit-to-stop-mandate/

LINK: https://rumble.com/vlblnr-dr.-peter-mccullough-destroys-vaxx-efficacy-narrative-united-pilots-file-su.html

Dec 20 2021

Doctor fired for spreading COVID misinformation finds supportive Crowd in Bartlesville.

Dr. Peter McCullough, a Dallas cardiologist who is largely discredited by the scientific community [Remember Dr McCullough is the MOST PUBLISHED AUTHOR OF SCIENTIFIC PAPERS IN THE USA.] for his assertions that the COVID-19 vaccines are unsafe and that early treatment options have been suppressed….
While McCullough said that doctors were probably afraid to show up to the event, one of Oklahoma’s top infectious disease physicians, Dr. Anuj Malik, director of infection prevention and control at Ascension St. John, said that the doctors he spoke to were not afraid to attend. They were just not interested in sitting through what would be seen as a “politically-motivated, ideological speech by a modern-day quack.”
Malik said. “With all due respect, none of McCullough’s ideas have been supported by any randomized, double-blind, controlled clinical trials,” [<=== THIS IS ALWAYS THE EXCUSE! NO data is allowed except that PAID FOR BY BIG PHARMA/NIH.]
McCullough shared what he said was a threatening letter from the American Board of Internal Medicine warning that he could lose his certification for spreading misinformation.
There is likely a good reason for his concern about losing certification. A Dallas County court granted a temporary restraining order against him in July on behalf of Baylor Scott & White Health for continuing to claim titles, including vice chief of internal medicine at Baylor University Medical Center, even after he was fired from Baylor in February.
In addition, an article in Medscape, an online global news source for physicians and healthcare professionals, reported that Texas A&M College of Medicine, Texas Christian University and University of North Texas Health Science Center School of Medicine have also cut ties with McCullough for spreading misinformation….

So the Baylor Connection made me curious.

And looky what I found! No wonder Baylor sued Dr McCollough in the hopes of shutting him up as they entice people to be lab rats!

June 8, 2021

Baylor launches clinical trial for COVID-19 vaccine booster

Researchers at the Vaccine and Treatment Evaluation Unit at Baylor College of Medicine have launched a clinical trial to study the safety and efficacy of a booster dose of the Moderna-mRNA-1273 COVID-19 vaccine…. The study is being conducted by the Infectious Disease Clinical Research Consortium in collaboration with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health…. “It’s important to determine the magnitude of the immune response after a booster dose in persons who received different vaccines in their initial vaccine regimen. We will also be looking at the safety of a booster dose,” said Dr. Robert Atmar, professor of infectious diseases at Baylor and co-principal investigator of the national study.
This activity is supported by the Infectious Diseases Clinical Research Consortium (IDCRC) through the National Institute of Allergy and Infectious Diseases (NIAID) (UM1AI148684). The IDCRC, consisting of the Vaccine Treatment and Evaluation Units (VTEUs) and the IDCRC Leadership Group, was formed in 2019 to support the planning and implementation of infectious diseases clinical research that efficiently addresses the scientific priorities of NIAID. The consortium includes infectious diseases leaders and clinical researchers from Emory University, University of Maryland School of Medicine, Baylor College of Medicine, Cincinnati Children’s Medical Center and University of Cincinnati, FHI360, Fred Hutchinson Cancer Research Center, Johns Hopkins University, Kaiser Permanente Washington Health Research Institute, New York University, Saint Louis University, Vanderbilt University Medical Center, University of Alabama at Birmingham, University of Rochester, University of Washington, and NIAID. For more information about the IDCRC, please visit www.IDCRC.org.

https://idcrc.org/_includes/images/group_fullv2.jpg

January 21, 2020, Rockville, MD [Above photo]

With presentations from members of the NIAID, the Infectious Diseases Clinical Research Consortium (IDCRC) Leadership Group, and VTEU PIs, the inaugural meeting of the IDCRC began with opening remarks from Anthony Fauci, MD, NIAID director. Session topics featured details on working with the NIAID, the Division of Microbiology and Infectious Diseases, and grants management. Breakout sessions facilitated thoughtful discuss on the consortium’s scientific agenda, flu, STIs, malaria, enteric, and emerging diseases, mentoring and career development, special populations, emerging lab sciences, and operations.
https://idcrc.org/about/index.html

Leadership Operations Center

The IDCRC institutions are leaders of influential infectious diseases, immunology and clinical research programs focused on vaccines and STIs at eight top academic institutions and affiliates across the country. The programs, faculty and collaborators at these institutions have exceptional NIH/NIAID network and international connectivity, a history of performing outstanding ID clinical research and the experience and capability of rapidly responding to ID threats.

Bio Robert Atmar

Dr. Atmar is a member of the Baylor Vaccine Research Center and the federally funded Vaccine Treatment and Evaluation Unit (VTEU). This research group performs Phase I to Phase IV studies of experimental and licensed vaccines, and Dr. Atmar serves as Principal Investigator or Co-Investigator for the clinical trials. Dr. Atmar and the research group have been involved in important studies that led to the licensure of live attenuated and high dose inactivated influenza virus vaccines. They also have performed many studies evaluating vaccines targeting pandemic influenza, including H5N1, H9N2 and H7N9 viruses, and they have evaluated methods to improve vaccine immunogenicity, including delivery of vaccine by different routes of administration, different dosages, and with different adjuvant preparations. The group has also evaluated vaccines targeting other pathogens, including those with importance to biodefense.

NIH Clinical Trials Baylor: LINK

484 ACTIVE Studies found for: Baylor College of Medicine | Recruiting, Enrolling by invitation Studies

2,625 studies found in data base [Baylor College] and 4195 for just Baylor.
24,250 studies – Just college

224,279 studies – University

SEE:
https://clinicaltrials.gov/ct2/results/details?cond=&term=university&cntry=&state=&city=&dist=&Search=Search

>

So is there a Robert Atmar – Hana El Sahly connection???

PubMed(dot)Gov lets you search by author name. So I went looking to see if those two authored papers together.

Search for Atmar R
https://pubmed.ncbi.nlm.nih.gov/?term=Atmar+R&sort=date&size=50

AND WELL WELL WELLL the first two out of the BOX!!!

2022 Jan 26.

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.

Pajon R, Doria-Rose NA, Shen X, Schmidt SD, O’Dell S, McDanal C, Feng W, Tong J, Eaton A, Maglinao M, Tang H, Manning KE, Edara VV, Lai L, Ellis M, Moore KM, Floyd K, Foster SL, Posavad CM, Atmar RL, Lyke KE, Zhou T, Wang L, Zhang Y, Gaudinski MR, Black WP, Gordon I, Guech M, Ledgerwood JE, Misasi JN, Widge A, Sullivan NJ, Roberts PC, Beigel JH, Korber B, Baden LR, El Sahly H, Chalkias S, Zhou H, Feng J, Girard B, Das R, Aunins A, Edwards DK, Suthar MS, Mascola JR, Montefiori DC.

N Engl J Med.

And the Affiliations:

• Moderna, Cambridge, MA.
• National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD.
• Duke University Medical Center, Durham, NC.
• NIAID, Bethesda, MD.
• Emory University School of Medicine, Atlanta, GA.
• Fred Hutchinson Cancer Research Center, Seattle, WA.
• Baylor College of Medicine, Houston, TX.
• University of Maryland School of Medicine, Baltimore, MD.
• National Institutes of Health, Bethesda, MD.
• Los Alamos National Laboratory, Los Alamos, NM.
• Brigham and Women’s Hospital, Boston, MA.
…..

2022 Jan 26.

Homologous and Heterologous Covid-19 Booster Vaccinations.

Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O’Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH; DMID 21-0012 Study Group.N Engl J Med.

Affiliation
• From the Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston (R.L.A., H.M.E.S.), and Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston (R.E.R.); the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.E.L., M.E.D., K.M.N.), and the Division of Microbiology and Infectious Diseases (S.C., S.U.N., P.C.R., J.H.B.) and the Vaccine Research Center (A.B.M., S.E.O.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda; Kaiser Permanente Washington Health Research Institute (L.A.J.), the Departments of Medicine (C.J., T.M.B., M.J. McElrath) and Laboratory Medicine and Pathology (C.J., C.M.P.), University of Washington, the Vaccine and Infectious Disease Division (C.J., C.M.P., C.P.D.I., E.R.B., M.J. McElrath) and the Statistical Center for HIV/AIDS Research and Prevention (D.S., J.A.Z.), Fred Hutchinson Cancer Research Center, and Seattle Children’s Research Institute (R.N.C.) and the Department of Pediatrics (R.N.C.), University of Washington School of Medicine, Seattle; the Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester (A.R.B., D.D.), NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York (M.J. Mulligan, A.C.K.), and NYU Langone Hospital-Long Island Vaccine Center Research Clinic and the Division of Infectious Disease, Department of Medicine, NYU Long Island School of Medicine, Mineola (M.B.) – all in New York; the Departments of Pediatrics (C.A.R.), Microbiology and Immunology (M.S.S.), and Medicine (S.E., D.S.S.), the Center for Childhood Infections and Vaccines (C.A.R.), Hope Clinic of Emory Vaccine Center (S.E.), Emory Vaccine Center, and Yerkes National Primate Research Center (M.S.S.), Emory University School of Medicine, Emory University, and Children’s Healthcare of Atlanta (C.A.R.) – all in Atlanta; the Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh (J.M.M., K.R.); Cincinnati Children’s Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati (R.C.B., R.W.F.); and FHI 360 (formerly Family Health International) (J.I.A.) and Duke Human Vaccine Institute (D.C.M.) and the Department of Surgery (D.C.M., A.E.), Duke University Medical Center, Durham, NC.

2021 Oct 15

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report.

Authors: Atmar RL,….. El Sahly HM…

EPub 2021 Sept 22
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.

El Sahly HM, … COVE Study Group. N Engl J Med. 2021 Nov 4….. Epub 2021 Sep 22….

PubMed lists: COVE Study Group [Corporate Author]

COVE STUDY GROUP:

Hana M. El Sahly, MD is principal investigator for Baylor and under her is listed
Jennifer A. Whitaker, C. Mary Healy, Christine Akamine, Wendy A Keitel, Robert L Atmar, Annette Nagel, Sandra Francisco, Thea Marie Cordero, Janet Brown, Jennifer Christensen, Caroline Doughty-Skierski, Connie Rangel, Carrie Kibler, Coni Cheesman, Lisreina Toro, Chanei Henry, Chianti Wade Bowers, Pedro Piedra, Kathy Bosworth, Kayla Burrell, Jesus Banay, Tykel Eddy, Trent Davis, Shetel Anassi, Yvette Rugeley, Olga Rybina-Willis
…..

So what about the OTHER 15 on the ‘Advisory Board’ I checked, none are in the COVE study group.

….

And one last Baylor – Atmar paper:

SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision.

Wang EW, Parchem JG, Atmar RL, Clark EH.Open Forum Infect Dis.

2021 Apr 10

Abstract
As the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines passed UK and US regulatory milestones in late 2020 and early 2021, multiple professional societies offered recommendations to assist pregnant and breastfeeding people as they choose whether to undergo vaccination. Despite such guidance, the lack of data describing vaccine safety, immunogenicity, and efficacy in pregnant and breastfeeding people has made this decision challenging for many. However, even considering the paucity of data, the known risks of coronavirus disease 2019 during pregnancy likely outweigh the not yet fully elucidated risks of SARS-CoV-2 vaccines, which have reassuring safety and efficacy profiles among nonpregnant people.

The Chair of the FDA Vaccines and Related Biological Products Advisory Committee is so compromised she should NEVER have been anywhere near the approval process!

-GC

Summary

After viewing the tape of Dr. Peter McCullough on Stew Peters, I’m both shocked and disappointed that Baylor (IMO both the College of Medicine and the allied University) would do anything except DEFEND Dr. McCullough for simply speaking TRUTH when nobody else dared to say it.

At a time when all of social media was defending what now amounts to SCIENTIFIC ERROR, Baylor – a renowned institution – accused a TRUTH-TELLER of “misinformation” for being on the cutting edge.

To borrow from Trump…… “SAD!”

We know now that everything Dr. Peter McCullough said was not only true, but that the science he cited was LEADING EDGE – pointing in the direction of future findings.

It is not “misinformation” to state scientific and medical findings which are both TRUE and in the process of CHANGING narratives. That IS what science is supposed to do.

China won’t have to fire a SHOT to steal academic leadership from the United States, if Baylor – in TEXAS of all places – is going to hand them scientific superiority on a silver platter.

Get the politics and the self-dealing OUT OF YOUR SCIENCE, BAYLOR.

It is a TRAVESTY for you, Baylor, to let your “big money scientists” force out your TRUTH-TELLERS based on POLITICS and motivated by their own SCIENTIFIC MISJUDGMENTS.

W

**A Book of Some Importance to Baptists**

Who Approved and Upheld These Vaccines? The Covid Second Opinion Forum Held by Ron Johnson vs. the FDA Vaccines & Related Biological Products Advisory Committee (VRBPAC)

A background research post by Gail Combs

PREFACE

by Wolf Moon

It is useful for me to explain Gail’s post – to help you understand the importance of it.

People in government regulation of science and medicine do not make decisions in a vacuum – but they may make their decisions in an artificial atmosphere which is created, composed, and altered by those with the extreme power and ability to CONTROL INFORMATION.

LancetGate was very demonstrative of this ability to control science and medicine.

After watching a variety of FDA decisions under the Trump and Biden administrations, it has become very clear to me that FDA resides in a political and economic crosswinds, highly influenced by many parties with strong expectations and abilities to influence. And yet, the shocking (but welcome) advisory recommendation AGAINST COVID vaccine boosters – then overridden by the political operative Rochelle ~~Alinsky~~ Walensky in CDC – shows how a coordinated injection of honest medicine and common sense into FDA decision-making (THANK YOU, Steve Kirsch!) can sometimes make its case heard – even if only momentarily.

Sadly, it seems to me that Pfizer is back in the driver’s seat again. We thus have to ask WHY.

What Gail has done is to look at one endpoint of the argument (frontline doctors and publishing scientists who have run into the problems), which leads to the other, where we begin to find the reasons why FDA generally decides things in favor of big industry and big government, and not to the benefit of individual patients and doctors.

By looking at the doctors and scientists who supported logical and ethical TREATMENT of COVID-19, and who were wrongly and unethically BLOCKED and DENIED PERMISSION at every point – we can see that undue industry and political influence in NIH, CDC, and FDA are most likely responsible for decisions that make absolutely no sense to truly independent scientists and doctors. The video Gail includes is rather astounding in terms of showing us how much went wrong. What we are now seeing reminds me of science and medicine in the Soviet Union. Absolutely incredible.

What Gail has done here is to “follow the influence” – to show that FDA decision-making has NOT been in a vacuum, precisely because the members of the FDA advisory committee are not truly independent, but are in fact actors for the very same powerful forces that benefit from FDA decisions which are now inscrutable at the doctor-patient frontline.

Perhaps even more astoundingly, the very SYSTEM of NIH, FDA, and CDC seems to be designed, at this point, to leave NOBODY ACCOUNTABLE. Advisory groups and even department responsibilities are created, rearranged, and dismissed, so that NOBODY takes responsibility for mandates that defy logic and even violate the common medical sense of the past.

If something goes wrong in this chaotic system of responsibilities in the wrong places, you either blame everybody or nobody at all. This is why, in my opinion, the entire federal governent had to get rid of Trump.

DIG ALONG WITH GAIL, as she finds the CLUES – first in the testimony of Ron Johnson’s witnesses – then in the backgrounds of members of an important FDA advisory panel.

With that, here’s Gail.

The Covid Second Opinion Forum

It would be nice to let Senator Johnson know we saw this:

CONTACT: https://www.ronjohnson.senate.gov/contact

Offices – Mail address and Phone: https://www.ronjohnson.senate.gov/office_locations

MANY THANKS TO GA/FL and Wolf M00n for alerting us to the Covid 2nd opinion Forum

Here’s a must watch – A SECOND OPINION – SENATOR RON JOHNSON FORUM.
Begins at 40:19 – https://rumble.com/vt62y6-covid-19-a-second-opinion.html
“Discussion begins around 40 minute mark. Sen. Ron Johnson moderates a panel discussion, COVID-19: A Second Opinion. A group of world renowned doctors and medical experts provide a different perspective on the global pandemic response, the current state of knowledge of early and hospital treatment, vaccine efficacy and safety, what went right, what went wrong, what should be done now, and what needs to be addressed long term.”
More at https://www.ronjohnson.senate.gov
GA/FL

It is five hours long and I went through the whole video. I recommend listening to it as you work on other things since there is not much to watch. It is much better than the speeches at the March Against Mandates.

My, comments posted 1/25/2020:
1:41:50 – 1:50:00 Dr Paul Marik on Remdesivir:
4 million hospitalized 850,000 million died. He says cheap approved drugs could have save 500,000 lives (That is the 1/2 million again that I figured out by a different method.)
He eviscerated NIH/FAUCI.

Fauci Told POTUS Remdesivir was good 10 days in. Researchers Changed the study END POINT to HIDE DEATHS. The OTHER study SHOWING the deaths/toxicity of Remdesivir in Ebola trial was released at 11:00 am JUST before the Afternoon presentation of the corrupted Remdesivir-Covid study that was presented by Fauci to POTUS. (More on this below) He also mentioned U.S. Centers for Medicare & Medicaid Services gives bonuses to hospital to treat MEDICARE (the old and ‘useless’) patients with this toxic drug.

Steve Kirsch made it clear he thought it was corruption and worse several times.

Incriminating evidence – Steve Kirsch’s newsletter
New VAERS analysis reveals hundreds of serious adverse Events that the CDC and EDA Never Told Us About

3:12:00 MyFreeDoctor (dot)com:
This group treated 150,000 and only lost four.

3:35:00 Dr Peter McCollough talks about vaccines:
Originally there were three different advisory boards during the trials but when it came to the EUA those boards were gotten rid of AND THAT IS WHY CLOT SHOT WAS NOT PULLED IN JANUARY 2021!
Steven Kirsch says right after that there is HARD evidence at least 4 in the CDC/FDA were getting royalties…

4:02:00
The risk increases with each shot. mRna was ENGINEERED to TAMP DOWN RESPONSE to evade ADE BUT it looks like it ALSO tamps down response to viruses, bacteria, and cancer.
New Study Dr Voss out of the Netherlands.
There are too many Dr Voss in the netherlands for me to hunt down the correct one.
https://pubmed.ncbi.nlm.nih.gov/?term=voss%20netherlands&sort=date
(Could be KL Koss since she has papers about the heart and colon and cancer. papers: https://pubmed.ncbi.nlm.nih.gov/?term=Koss+KL&cauthor_id=8943944

4:43:00 Attorney Tom Renz:

He has Dept of Defense Whistleblowers with the data from the D-Med data base. They have taken data ‘snapshots’ over time and it shows THE DATA BASE WAS TAMPERED WITH TO HIDE THE INJURIES TO OUR SOLDIERS!
Senator Johnson Ordered PRESERVE YOUR RECORDS….

January 25, 2022 14:52
Apparently Daniel Horowitz chased down Attorney after the Ron Johonson Senate Hearing for some additional clarifications.
https://thelibertydaily.com/bombshell-cover-up-cancer-diagnoses-in-the-military-rose-over-three-fold-since-jabs-were-introduced/
para59r

5:05:00
Myocarditis and heart Hits 18 to 24 yr old males the worst. up to 50 years 21,000 cases so far.
A lot more good info.

Dr. Christina Parks made comments through out the presentation.

January 25, 2022 20:09
Yes – Dr. Christina Parks has made some excellent points about how differently people with African genetic background react to CV19 AND THE VACCINES.
Ethnicity does matter in medicine – my sister had concurrent dengue fever and malaria and her response was severe and peculiar to a certain ethnicity so….we learned may have some middle eastern/african blood somewhere previously unknown to us.
GA/FL

The Timeline of FDA Decisions

Heading down the Rabbit Hole on Vaccines that Dr Peter McCollough opened.

Emergency Use Authorization — FDA
As background, this gives the laws, who has the authority and the timeline.

TIME LINE:

October 13, 1976 – New York Times:
Swine Flu Program Is Halted in 9 States As 3 Die After Shots
“After the deaths, swine flu vaccinations were halted throughout Allegheny County, which includes Pittsburgh, and the Federal Center for Disease Control sent doctors to investigate….“

September 1, 2020 CNN
Past vaccine disasters show why rushing a Covid-19 vaccine now would be ‘colossally stupid’
This is actually a very good article on BAD vaccines and what it can do to the public’s trust.

And then we come to the FDA, the meetings and WHO is on the board.

October 22, 2020
Discussing, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19

On October 22, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session, to discuss, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19.
FDA

Those are probably the three boards Dr Peter McCollough talks about. The third was the FDA Vaccines and Related Biological Products Advisory Committee that hold these meetings. Note they are meeting just before the election and it contains ALL three boards.
….

These meetings are AFTER the STOLEN ELECTION but again all three advisory boards are present.

December 10, 2020
Discussing First Emergency Use Authorization Request for a COVID-19 Vaccine

On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.
FDA

December 17,2020

Discussing Second Emergency Use Authorization Request for a COVID-19 Vaccine

Agenda
The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On December 17, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Moderna, Inc., COVID-19 Vaccine for the prevention of COVID-19 in individuals 18 years and older.
FDA

December 15, 2020 updated December 18

The ACIP met last week to review the Pfizer-BioNTech vaccine and recommended moving forward with its distribution to anyone over age 16. The FDA issued an EUA on Saturday following the meeting and notified the CDC and Operation Warp Speed to coordinate distribution plans. Initial doses were shipped over the weekend. The first round of deliveries will be completed in all 50 states this week…
Pfizer’s initial distribution of vaccines will be given to 21 million health care workers and 3 million mostly elderly people living in long-term care facilities.
As vaccines are deployed, data on potential or delayed side effects will be collected to answer questions that would have been addressed in long-term trials with millions of participants under nonemergency circumstances….
Nat’l Conf. of State Legislators

December 14, 2020, 8:33 PM – Black nurse in New York, Sandra Lindsay, gets the first vaccine.

A month later we get the first Adverse Reaction Reports.
January 18, 2021 – Coronavirus: California calls for pause, investigation after Allergic Reactions to Moderna Vaccine

Biden is installed in the White House and the FDA/CDC does no real investigation. Instead NOTE THE CHANGE IN MEETING MINUTES.

February 26, 2021
Discussing Third Emergency Use Authorization Request for a COVID-19 Vaccine

Agenda
The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. The committee will meet in open session to discuss EUA of the Janssen Biotech Inc. COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years and older. <== NO ADDITIONAL ADVISORY BOARDS!
Meeting Materials
FDA intends to make background material available to the public no later than 2 business days before the meeting. <== THIS IS THE INFORMATION people are having to SUE FOR!
FDA

Note there are NO MEETINGS TO DISCUSS DEATHS OR ADVERSE REACTIONS! This is the NEXT MEETING:

June 10, 2021

Discussing Pediatric Use of COVID-19 Vaccines

The Committee will meet in open session to discuss, in general, data needed to support authorization and/or licensure of COVID-19 vaccines for use in pediatric populations.
Meeting Materials
FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting….
FDA

Now we come to the meat, exactly who is at those meetings?

The VRBPAC Advisory Committee

The Committee reviews and evaluates data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products which are intended for use in the prevention, treatment, or diagnosis of human diseases, and, as required, any other products for which the Food and Drug Administration has regulatory responsibility. The Committee also considers the quality and relevance of FDA’s research program which provides scientific support for the regulation of these products and makes appropriate recommendations to the Commissioner of Food and Drugs.
The Committee shall consist of a core of 15 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of immunology, molecular biology, rDNA, virology; bacteriology, epidemiology or biostatistics, vaccine policy, vaccine safety science, federal immunization activities, vaccine development including translational and clinical evaluation programs, allergy, preventive medicine, infectious diseases, pediatrics, microbiology, and biochemistry.
FDA

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees….
Conflicts of Interest:
Potential candidates are asked to provide detailed information concerning such matters as financial holdings, employment, and research grants and/or contracts in order to permit evaluation of possible sources of conflict of interest.
FDA

Oooh Boy, they do not sound good. I am digging up and placing here a lot of info on each individual. However I have screened out much much more. What struck me, is out of the sixteen only three do not have major expertise in pediatrics. ALL have ties to NIH/Fauxi or the FDA or the CDC. Some have ties to drug companies and more than one has ties to China. Most are women and three are foreign educated and probably not American born. Out of over 300 million people, you would think they could find Americans.

First a cameo of each of the players, and then if you wish you can look at some of the other information I dug out. If you click on the name it takes you to the information they provided to the FDA, often pages and pages citing the papers they wrote and who they worked for. This is the information I used with some added from other sources.

CAMEOS

DIRECTOR
Prabhakara Atreya, Female connected to Fauci She has no FDA bio.

Ph.D. biochemistry Memorial University of Newfoundland, in Canada 1987

Wayne State University, School of Medicine, Detroit, MI 1989 – 1990 (messing with fiber cell membranes of frog, chick, bovine, rabbit and human lenses)

Plant Pathology, University of Kentucky, Lexington KY – Papers 1990 &1995

FDA since 2010 per BIO but actually a paper shows she was working @ FDA in 1999.

NIH paper shows she was at NIH in 1998
Plant Pathology, University of Kentucky, Lexington KY – Papers 1990 &1995 (Only 13 papers found)

…..

Chair
Hana El Sahly, M.D.
Baylor College of Medicine (Woman)

Wrote paper on Remdesivir used by Fauci to trick President Trump. The one referred to by DR. McCullough

…..

Paula Annunziato, M.D. ***
Vice President and Therapeutic Area HeadVaccines Clinical ResearchMerck

Seems to specialize in Pediatric Vaccines.

Archana Chatterjee, M.D., Ph.D.
Dean Chicago Medical School (Woman)

specialises Pediatrics Vaccines

Pune University, Maharashtra, India 1979-1983

Army Medical Corps, Military Hospital, Gaya, India, 1985 -1988

She is nationally recognized for her work in vaccine development for human papilloma viruses – think Gardasil. I wonder how well acquainted she is with Gregg Sylvester, below & Bill Gates? – Controversial vaccine studies: Gates and Infertility

…….

CAPT Amanda Cohn, M.D.
Expertise: Pediatrics, Vaccines

Chief Medical Officer – National Center for Immunizations and Respiratory Diseases – CDC
The mission of the National Center for Immunization and Respiratory Diseases (NCIRD) is the prevention of disease, disability, and death through immunization

59 Scientific papers: many authored with Nancy E Messonnier

Time to check the Atlantia graveyards… And I am NOT kidding.

…..

Hayley Gans, M.D. (woman)
Expertise: Pediatrics, Infectious Diseases
Department of Pediatrics
Stanford University Medical Center

Author with a bunch of Chinese with FUNDING from China, using the bogus PCR test to say people who have recovered can catch Covid again and re-infect others. This is WHY natural immunity was never on the table and vaccines were.

….

Holly Janes, Ph.D.
Expertise: Biostatistics
Professor – Fred Hutchinson Cancer Research Center
Vaccine and Infectious Disease Division
Division of Public Health Sciences – Seattle, WA

Holly is a biostatistician working on the design and analysis of vaccine studies, with a particular expertise in HIV prevention and vaccine science. Worked for NIH and Bill & Melinda Gates Foundation.

…..

Michael Kurilla, M.D., Ph.D.
Expertise: Infectious Diseases, Pathology
Director, Division of Clinical Innovation National Center for Advancing Translation Sciences
National Institutes of Health (NIH <– He works for Fauci)
Bethesda, MD 20852

….

Myron Levine, M.D., D.T.P.H., F.A.A.P

Expertise: Infectious Diseases

Associate Dean for Global Health – Vaccinology and Infectious Diseases

Center for Vaccine Development – University of Maryland School of Medicine Baltimore, MD

Faculty at CVD have served in critical leadership roles in U.S. and international research and policy efforts. For example, Neuzil co-chaired the COVID-19 Prevention Trials Network, a research network established by the National Institute of Allergy and Infectious Diseases [ Dr. Fauci was appointed director of NIAID in 1984.] in response to the pandemic. Vaccine research at CVD continues, with an emphasis on reaching the populations most impacted by COVID-19 and testing pediatric vaccines.
University of Maryland

….

H. Cody Meissner, M.D. (Male)
Expertise: Infectious Diseases

Professor of Pediatrics – Tufts University School of Medicine
Director, Pediatric Infectious Disease

H. Cody Meissner, MD, is a leading national expert on childhood vaccinations who consults with the Centers for Disease Control and Prevention on periodic updates to the recommended immunization schedule for newborns through 18-year-olds. At Tufts Children’s Hospital at Tufts Medical Center he heads the Division of Pediatric Infectious Diseases…
H. Cody Meissner, MD, Vice Chair (’19)
H. Cody Meissner, MD | Tufts Medical Center

…..

Paul Offit, M.D.

Expertise: Infectious Diseases

Professor of Pediatrics, Division of Infectious Diseases, The Children’s Hospital of Philadelphia

Paul A. Offit, MD is the Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia as well as the Maurice R. Hilleman Professor of Vaccinology and a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, and a Research Career Development Award from the National Institutes of Health. Dr. Offit has published more than 160 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety….
FDA

In 2017, Dr. Offit was a weekly columnist for The Daily Beast.

A look at his recent peer-reviewed papers shows he is targeting vaccine hesitant parents.

https://pubmed.ncbi.nlm.nih.gov/?term=Offit+PA&cauthor_id=24011750&size=20

This says it all:

Plotkin SA, Offit PA, Reiss D.: Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines. Pediatr Infect Dis J. 37(12), Dec. 2018.

To the Editors:

Vaccination is under attack by individuals who occasionally use the legal system to oppose mandatory vaccination laws and in some cases to obtain exemptions for particular children whose parents are opposed to vaccination. During the legal proceedings, as we have witnessed, experts testifying in favor of vaccination may be challenged with references from journals of doubtful quality that oppose vaccination.
To provide important references that discuss and disprove claims made against vaccines, the Vaccine Education Center at the Children’s Hospital of Philadelphia has created a library of references addressing certain safety issues that may be useful as an aid and refresher to clinicians giving expert testimony on the safety of vaccines and to lawyers defending vaccination of children.
The Children’s Hospital of Philadelphia legal library may be entered through the web address vaccine.chop.edu/safety-references.
We would be grateful if you could inform your colleagues about the availability of this resource, which should be of great value for experts testifying for vaccination and for clinicians who need to convince parents about vaccine safety. https://journals.lww.com/pidj/Fulltext/2018/12000/Important_New_Resource_for_Clinicians_Giving.42.aspx
The Pediatric Infectious Disease Journal

………..

Steven Pergam, M.D.
Expertise: Infectious Diseases
Medical Director
Infection Prevention
Seattle Cancer Care Alliance — Seattle, WA

He seems to specialize in cancer and immuno-compromised and seems to be the best of a bad bunch, until you see he is tied at the hip to NIH & CDC from 2009 to present as well as to various drug companies.

….

Jay Portnoy, M.D.

Expertise: Consumer Representative (This is the guy representing the public)

Professor of Pediatrics

Medical Director of Telemedicine Section of Allergy, Asthma and Immunology

Children’s Mercy Hospital Kansas City, MO

150 papers mainly on allergies. American College of Allergy, Asthma & Immunology – “…a professional medical association of more than 6,000 allergist-immunologists and allied health professionals…” AND if you search long enough…. You find the American College of Allergy, Asthma & Immunology wrote an Article urging allergists to support more funding for NIH (Fauci)

He is also on a Task Force Paper recommending those with severe egg allergies to go ahead and get the Flu vaccine, just do it at the allergist because “… personnel to recognize and equipment to treat anaphylaxis need to be immediately available…”

….

Andrea Shane, M.D., M.P.H., M.Sc.

Expertise: Pediatric & Infectious Diseases

Professor of Pediatrics, Director Division of Pediatric Infectious Diseases – Emory University School of Medicine – Atlanta, GA

International exchange fellowship, Children’s Hospital at Montefiore and Beijing Children’s Hospital, Beijing, China October-November, 1999

Lieutenant Commander, United States Public Health Service, 2001-2003;

Inactive Reserve Corps (IRC) 2003-until IRC dissolved in 2010.

Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices (ACIP) respiratory syncytial virus (RSV) immunoprophylaxis working group, appointed member, 2009-until committee dissolved by CDC in 2011.

01 August 2007- 01 August 2016 Co- investigator, NIH/NIAID/DMID Vaccine and Treatment Evaluation Unit (VTEU)

influenza vaccine to breastfeeding women trial, DMID#09-007;

…..

Paul Spearman, M.D.
Expertise: Pediatric & Infectious Diseases

Director, Division of Infectious Diseases
Albert B. Sabin Chair in Pediatric Infectious Diseases
Cincinnati Children’s Hospital Medical Center
Professor, Department of Pediatrics
University of Cincinnati School of Medicine Cincinnati, OH

This guy is a really big heavy weight.

There is cross-over with the lady above, Andrea Shane. Any bets he pulled her in to be his ‘female puppet’ – a good little government soldier?

03/2009-09/2016: Vice Chair for Research Department of Pediatrics Emory University School of Medicine

03/2009-09/2016: Chief Research Officer Children’s Healthcare of Atlanta Atlanta, GA

[Andrea Shane is Attending Pediatrician Children’s Healthcare of Atlanta Emory Healthcare Grady Health 2006 – present ]

This guy has a full page of COMMITTEE MEMBERSHIPS, National and International, and a whole section for NIH Councils and Study Sections AND… NIH/NIAID HIV Vaccine Trials Network – Protocol Chair, HVTN 088 Protocol 2010-present

Not to mention his connections to the drug companies and China.

………

Geeta K. Swamy, M.D.
Expertise: Infectious Diseases
Senior Associate Dean Vice Chair for Research & Faculty Development
Associate Professor, ObGyn, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine
Duke University, Durham, NC

2004 – 2006 Duke University Associate Faculty Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine & Division of Clinical & Epidemiological Research

2009 – present Duke University Vaccine Trials Unit Investigator Duke Translational Research Institute Durham, NC

Grants from, NIH-NIAID, GlaxoSmithKline, CDC-NCIRD, ACOG/Merck & Company,

2015

Consultative Workshop: Immunology Research Gaps Related to Maternal Immunization – Bill & Melinda Gates Foundation

WHO Brighton Collaboration Global Alignment of Immunization Safety Assessment in Pregnancy – Chair, Fetal Distress Working Group

…

Gregg Sylvester, M.D., M.P.H. +
Expertise: Alternate Industry Representative
Vice President – Medical Affairs, Seqirus Inc., Summit, NJ

• Launched Pfizer’s Pediatric and Adult Pneumococcal conjugate vaccine,

Spearheaded science-based rationale to preserve Pfizer’s Prevnar 13 infant schedule in US recommendations

• Launched Merck’s HPV4 vaccine in over 100 countries

• Partnered with community organizations in Delaware to reduce infant mortality, teen pregnancy rates and HIV rates

Created the medical affairs strategy for Merck’s HPV4 vaccine, Gardasil

….

Vaccine Approval For Children

Now, if you have time & stomach, a deeper dive into the people who unleashed the Clot Shot on babies.

DIRECTOR
Prabhakara Atreya, Ph.D.
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
Food and Drug Administration – Silver Spring, MD

Dr. Prabhakara Atreya, an Indian American scientist is a 10 year veteran at the US Food and Drug Administration which she joined in 2010. Prior to this appointment, Atreya worked at the National Institutes of Health, leading the Office of Scientific Review. She has a PhD in biochemistry, biophysics and molecular biology from the Memorial University of Newfoundland, in Canada. She was one of the team of US regulators and independent experts of Vaccines and Related Biological Products Advisory Committee (VRBPAC). At the time of emergency use authorization for Pfizer’s Covid-19 vaccine, she was the Acting Designated Federal Officer of VRBPAC.
LINKED-IN

Thesis:
Atreya, Prabhakara Lakshmi (1987) Conformational aspects of proline hydroxylation in collagen biosynthesis : studies with synthetic peptides. Doctoral (PhD) thesis, Memorial University of Newfoundland.

Probable Papers (13):
Affiliation: Department of Plant Pathology, University of Kentucky, Lexington
I think this paper is what Fauci Spotted:
Construction of in-frame chimeric plant viral genes by simplified PCR strategies.
Atreya CD, Atreya PL, Pirone TP. Plant Mol Biol. 1992 Jun;19

Site-directed mutations in the potyvirus HC-Pro gene affect helper component activity, virus accumulation, and symptom expression in infected tobacco plants.
Atreya CD, Atreya PL, Thornbury DW, Pirone TP.Virology. 1992 Nov

Mutational analysis of the coat protein N-terminal amino acids involved in potyvirus transmission by aphids.
Atreya PL, Lopez-Moya JJ, Chu M, Atreya CD, Pirone TP.J Gen Virol. 1995 Feb;76
…
Her papers then show a move to NIH
Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0720, USA.
The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.
Atreya PL, Peeples ME, Collins PL.J Virol. 1998 Feb;

And then the move to FDA.
Affiliation: Laboratory of Pediatric and Respiratory Viral Diseases, DVP/CBER, Food and Drug Administration, Bethesda, MD 20892, USA.
Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
Atreya PL, Kulkarni S.Virology. 1999 Sep 1; (@ FDA)

Role of type I IFNs in the in vitro attenuation of live, temperature-sensitive vaccine strains of human respiratory syncytial virus.
Loveys DA, Kulkarni S, Atreya PL.Virology. 2000 Jun

……..
Her resume STINKS! She has three papers on human respiratory syncytial virus, and a bunch of early papers on cloning and tinkering with plants @ Univ Kentucky and earlier papers messing with fiber cell membranes of frog, chick, bovine, rabbit and human eye lenses @ Wayne State Univ, MI NOTHING ELSE except the Sex Card, Race Card and probably not American born.
……..

These are her picks:

CHAIR:
Hana El Sahly, M.D.
Baylor College of Medicine
May 18, 2020
Hana El Sahly on Remdesivir and the NIH’s Adaptive COVID-19 Treatment Trial (Well that answers WHO set up elders for DEATH!)

On May 15, Texas Monthly reported on their conversation with Dr. Hana El Sahly of Houston’s Baylor College of Medicine. In the coming days, she will begin registering hospitalized participants at Baylor St. Luke’s Medical Center and Ben Taub Hospital for the second phase of the National Institutes of Health’s Adaptive COVID-19 Treatment Trial, or ACTT. She’s Baylor’s lead investigator for participation in the program, which in its first phase analyzed a randomized, controlled trial designed to evaluate the safety and efficacy of the investigational antiviral remdesivir. Preliminary findings suggested that patients treated with remdesivir recovered faster than patients who received a placebo, which led to the May 1 announcement that remdesivir would be the first medication to receive FDA authorization for emergency use for COVID-19.
“We found that for patients who have COVID-19 pneumonia bad enough to get them to the hospital, treatment with remdesivir expedites the time to recovery by an average of four days per patient,” says El Sahly…
Hana El Sahly, M.D.

Education

Undergraduate education American University of Beirut, Lebannon Bachelor of Science, 1987-1990Medical education American University of Beirut, Lebannon School of Medicine, Doctor of Medicine, 1990-1994

Scientific Papers (46)

Several presentations on “HIV vaccines”
Fauci must love her:

Review Panels, Committees
Member, Safety Monitoring Committee, National Institutes of Health-sponsored vaccine clinical trial 05-0011; 2006
Reviewer, Loan Repayment Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health; 2008
Member, Safety Monitoring Committee, National Institutes of Health-sponsored vaccine clinical trial 08-0009; 2009
Reviewer, Scientific Review Program, National Institute of Allergy and Infectious Diseases; 2010
Member, Data Safety Monitoring Board, Protein Sciences Corporation vaccine clinical trial PSC-22; 2010
Member, Safety Monitoring Committee, National Institutes of Health–sponsored study DMID 10-0043; 2011
Member, Safety Monitoring Committee, National Institutes of Health-sponsored study DMID 11-0007; 2011
Reviewer, Scientific Review Program, National Institutes of Health, P01 application “Towards A Universal Influenza Vaccine”; 2012
Member, Safety Monitoring Committee, National Institutes of Health sponsored study DMID 13-0087; 2014
Member, Publications Committee, Infectious Diseases Society of America; 2014-2017
Member, Safety Monitoring Committee, Mercia Pharma Inc-sponsored study NOVA MAS-1; 2015
Member of the Food and Drug Administration Vaccine and Related Biological Advisory Committee; 2016–
Reviewer, Influenza pre-applications, US Army Medical Research and Materiel Command-Congressionally Directed Medical Research Programs, 2016
WHAT THE HECK IS THIS!! => Member, ID week program planning committee, 2017-2019

Is this her daughter: Dr. Hana Mohammed Elsahly, MD 28, practicing in Houston, TX?
……

Paula Annunziato, M.D. ***
Vice President and Therapeutic Area Head
Vaccines Clinical Research
Merck
Seems to specialize in Pediatric Vaccines.
Nuv said…

…..

Archana Chatterjee, M.D., Ph.D.
Dean Chicago Medical School
Vice President for Medical Affairs
Rosalind Franklin University of Medicine and Science
M.B.B.S. (Equivalent to M.D.): Pune University, Maharashtra, India 1979-1983
Army Medical Corps, Military Hospital, Gaya, India, 1985 -1988
Major Scientific Interest: Vaccine development. She forgets to mention her main trial target is infants.

Principal Investigator: Recent Research Projects/Grants
GSK = GlaxoSmithKlinePled Guilty and Pay $3 Billion to Resolve Fraud Allegations & Failure to Report Safety Data – July 2012
(Nice people she worked for.)

Date: 2018-2019 Sponsor: Department of Health and Human Services, Administration For Community Living

Date: 2018-2020 Sponsor: Pfizer A Phase 2, Randomized,Trial ….Pneumococcal Conjugate Vaccine in Healthy Infants.

Date: 2018-2020 Sponsor: GSK …Study to Assess the Safety & Immunogenicity of Meningococcal Vaccine & 1 Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Healthy Infants.

Date: 2018-2020 Sponsor: GSK … dose-escalation study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ respiratory syncytial virus (RSV) investigational vaccine based on the RSV viral proteins F, N and M2-1 encoded by chimpanzee-derived adenovector.. when administered… to RSVseropositive infants aged 12 to 23 months.

Date: 2017-2019 Sponsor: MedImmune ….Study to Evaluate the Safety and Efficacy of MED18897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants. [Are they going to give the infants the RSV?]

Date: 10/2015-10/2017 Sponsor: Merck…, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 [15-valent pneumococcal conjugate vaccine ] in Healthy Adults and Infants.

Date: 10/2015-10/2016 Sponsor: Astra Zeneca An observational study of RSV hospitalization in preterm infants.

Date: 9/2014-2017 Sponsor: GSK … multinational study … of GSK Biologicals’ MMR vaccine (209762)… compared to Merck (M-M-R®II or VaxPro), as a first dose, both co-administered with Varivax, Havrix (all subjects) and Prevnar 13 (US subset) in healthy children 12 to 15 months of age.

Peer-Reviewed Articles (120)

Appointments:
2020 – Invited to serve on NIH (NCI) Special Emphasis Panel to evaluate grant applications received in response to the RFA(s) with primary focus on HIV-Associated Malignancy Research

2019 to present – Invited to serve as and appointed a member on the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the United States Food and Drug Administration (US FDA)

2012 -2019 – Consultant to the US FDA

2014 – Merck Vision 2027 Expert Input Forum on Vaccine Policy

2008 – 2012 – Member, Anti Infective Drug Advisory Committee (AIDAC), Center for Drug Evaluation and Research, US FDA

2008 -2012 – Invited to serve on the National Vaccine Advisory Boards for Merck, GlaxoSmithKline and Novartis Pharmaceutical Companies

2008– Merck Vaccination Service Award, recognition of commitment to improving public health through vaccination.

2006 – Invited member, Sanofi-Pasteur, MedImmune, Abbott Pharmaceutical Companies’ National Advisory Boards

2003 – Invited Session Chair at an International Symposium organized by the Merieux Foundation entitled, “Vaccination in Tomorrow’s Society – New Information Pathways”. Annecy, France

Merieux Foundation …. AND THAT GETS INTERESTING…. WIKI

In October 2004, the FM was the beneficiary of a Franco-Chinese agreement that led to the creation of the Institut Pasteur de Shanghai.…
In 2012, the FM continued its partnership with the Chinese Academy of Medical Sciences.
In 2015, the CAMS-FM partnership founded the Christophe Mérieux Laboratory (CML) at the Institute of Pathogen Biology in Beijing to focus on the study pneumonia and tuberculosis. Researchers at the CML “benefit from and training modules developed by the Emerging Pathogens Laboratory in Lyon”,[5][6] a BSL-4 lab which was also built by the FM in 1999 and since 2005 is now operated by INSERM.[7]
In 2015, the FM participated in the donation by the French government of CIRI’s Biosafety Level 4 expertise to the Wuhan Institute of Virology.
In January 2017, a researcher who was financed by the CAMS-FM partnership participated in a study of human rhinovirus and genotype A21…..
https://en.wikipedia.org/wiki/Fondation_M%C3%A9rieux
WIKI

“Mentorship and sponsorship of faculty and learners has been a hallmark of Dr. Chatterjee’s entire thirty- year career in academic medicine…” LINK [I am sure she has been kissing FauXi’s ass for years to get funding.]
MORE:

….Board certified in general pediatrics and pediatric infectious diseases, she is nationally recognized for her work in vaccine development for human papilloma viruses and in antibiotic resistance. She has completed more than 100 clinical trials and published more than 50 peer-reviewed articles, 23 invited review articles, 17 book chapters and one book.
The first woman and person of color to serve as dean of CMS, Dr. Chatterjee, a native of India, earned her medical degree from the Armed Forces Medical College at Pune University in India and her PhD from the University of Nebraska Medical Center (UNMC) in Omaha….
https://www.rosalindfranklin.edu/news/rfu-announces-selection-of-new-dean-for-chicago-medical-school/

…..

CAPT Amanda Cohn, M.D.
Expertise: Pediatrics, Vaccines
Chief Medical Officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention

Immunization and Respiratory Diseases (NCIRD) MISSION | CDC
The mission of the National Center for Immunization and Respiratory Diseases (NCIRD) is the prevention of disease, disability, and death through immunization and by control of respiratory and related diseases.
CDC

POSTGRADUATE TRAINING 2004 – 2006 Epidemic Intelligence Service, CDC, Atlanta, GA
WORK EXPERIENCE :
3/2019-present Chief Medical Officer (Acting), Vaccine Policy, Preparedness, and Global Health, Office of the Director, NCIRD, CDC
11/2015-present Executive Secretary, ACIP and Senior Advisor, Vaccines Office of the Director, NCIRD, CDC
5/2014-11/2015 Deputy Division Director, Immunization Services Division, NCIRD, CDC
01/2013-05/2014 Acting Epidemiology Team Lead Meningitis and Vaccine Preventable Diseases, DBD, NCIRD, OD
06/2006-12/2012 Medical Officer, Epidemiology Team Meningitis and Vaccine Preventable Diseases, Division of Bacterial Disease, NCIRD, CDC
07/2004-06/2006 Epidemic Intelligence Service (EIS) Officer, Epidemiology Program Office Centers for Disease Control and Prevention, Atlanta, GA Assigned to: Bacterial Vaccine Preventable Diseases Branch, National Immunization Program

Scientific papers: 59 many authored with Nancy E Messonnier
Great titles like:

Multistate Outbreak of Respiratory Infections Among Unaccompanied Children, June 2014-July 2014.
Conclusions: This respiratory disease outbreak was due to multiple pathogens, including Streptococcus pneumoniae serotype 5 and influenza viruses. Pneumococcal and influenza vaccinations prevented further transmission. Future efforts to prevent similar outbreaks will benefit from use of both vaccines. https://pubmed.ncbi.nlm.nih.gov/27001799/
[How about CLOSING THE DARN BORDERS!]
Understanding Factors Affecting University A Students’ Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine.
Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen.
Adolescent immunizations and other clinical preventive services: a needle and a hook?
Immunizations in the United States: a rite of passage.
Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth.
……

Hayley Gans, M.D.
Expertise: Pediatrics, Infectious Diseases
Professor of Pediatrics
Department of Pediatrics
Stanford University Medical Center

Fellowship: Stanford University School of Medicine (1998) CA

Medical Education: State University of New York Syracuse Medical School Registrar (1991) NY
Board Certification: American Board of Pediatrics, Pediatric Infectious Diseases (1999)
Residency: Stanford University Medical Center (1994) CA
Internship: Stanford University Medical Center (1992) CA
M.D., SUNY at Syracuse, Medicine (1991)

Fellowship Program Director, Pediatric Infectious Diseases (2006 – 2017)

Co-director, Pediatric Infectious Diseases Program for Immunocompromised Hosts, Children’s Hospital at Stanford (2013 – Present)
Associate Fellowship Director, Pediatric Infectious Diseases, Stanford University Medical Center (2017 – Present)
Director, Fellowship Education, Department of Pediatrics, Stanford University Medical Center (2017 – Present)

Sort of BLAAaaaah until you look at this paper:

Remember her focus is kids.

July 2020 Lancet preprint.
Kinetics of SARS-CoV-2 Positivity of Infected and Recovered Patients: A Single Center COVID-19 Experience and Potential Implications https://autopapers.ssrn.com/sol3/papers.cfm?abstract_id=3605268

Jia Huang – Southern University of Science and Technology CHINA and 42 other authors with only 7 others not Chinese. The other universities were Sichuan University, China and Sanford.

https://autopapers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=4257785

And then it REALLY GETS GOOD:

FUNDING STATEMENT: This work was supported by grants from Sanming Project of Medicine in Shenzhen (Jia Huang, No. SZSM201812065); Bill & Melinda Gates Foundations (Lei Liu); and from National Natural Science Foundation of China (Jia Huang, No. 81501651)

DECLARATION OF INTERESTS: The authors declare no competing interests.

ETHICS APPROVAL STATEMENT: This study was approved by the Ethics Committee of the Second Affiliated Hospital of Southern University of Science and Technology.[CHINA]

Abstract

BACKGROUND: Recurrence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive detection in infected but recovered individuals has been reported. Patients who have recovered from coronavirus disease 2019 (COVID-19) could profoundly impact the health care system if a subset were to be polymerase chain reaction (PCR)-positive again with reactivated SARS-CoV-2. We sought to define the kinetics and relevance of PCR-positive recurrence during recovery from acute COVID-19 to better understand risks for prolonged infectivity and reinfection.

METHODS: A series of COVID-19 414 patients, at The Second Affiliated Hospital of Southern University of Science and Technology in Shenzhen, China from January 11 to April 23, 2020. Univariable and multivariable statistical analysis of inpatient data were performed to develop an algorithm to predict patients at risk of recurrence of PCR positivity.
[REMEMBER PCR TESTS RETURN MAJOR FALSE POSITIVES – Reiner Fuellmich say this guy Droston isn’t a Doctor at all, but a bull**** artist. Christian Drosten & the Fraud Behind COVID 19 PCR Testing ]
FINDINGS: 16·7% recovered patients with PCR positive recurring one to three times, despite being in strict quarantine. Younger patients with mild pulmonary respiratory syndrome had higher risk of PCR positivity recurrence. The recurrence prediction model had an area under the ROC curve of 0·786.

INTERPRETATION: This case series provides clinical characteristics of recovered COVID-19 patients with recurrent SARS-CoV-2 positivity, despite strict quarantine, at a 16·7% rate. Use of a recurrence prediction algorithm may identify patients at high risk of recurrent SARS-CoV-2 positivity and help understand reactivation and reinfection possibilities to establish protocols for health policy.
LANCET

This is a very important paper because it REFUTES NATURAL IMMUNITY and green lights MORE DRACONIAN ECONOMY KILLING ‘Health Measures’

……

Holly Janes, Ph.D.
Expertise: Biostatistics
Professor — Fred Hutchinson Cancer Research Center
Vaccine and Infectious Disease Division
Division of Public Health Sciences – Seattle, WA

Dr. Holly Janes is a biostatistician working on the design and analysis of vaccine studies, with a particular expertise in HIV prevention and vaccine science. She also develops and applies statistical methodology for evaluating biomarkers for risk prediction and optimizing treatment decisions

Current Projects

Leadership for the Statistical Data Management Center of the HIV Vaccine Trials Network

Statistical methods for HIV prevention efficacy trials

Statistical methods for human challenge studies

Statistical evaluation of biomarkers for making treatment decisions https://www.fredhutch.org/en/faculty-lab-directory/janes-holly.html

HONORS, AWARDS, SCHOLARSHIPS:

2008 Travel Award, AIDS Vaccine Conference, Global HIV Vaccine Enterprise

2000 Cardiovascular Biostatistics Training Grant, National Institutes of Health

EDITORIAL RESPONSIBILITIES:

Associate Editor Journal of the National Cancer Institute (2015-2018)

Diagnostic and Prognostic Research (2016-present)

Statistical Communications in Infectious Diseases (2019-present)

RESEARCH FUNDING:

Active Funding:

2 UM1 AI068635 (PI: Gilbert P) 01/01/2014 – 11/30/2020 5.4 Calendar NIH/NIAID SDMC HIV Vaccine Trials Network

2 R01 CA152089 (PI: Janes H) 07/01/2010 – 11/30/2021 4.8 Calendar

NIH/NCI

Statistical Methods for Evaluating Markers for Treatment Selection

Interventions for disease treatment and prevention can potentially be made more cost-effective by using markers to identify in advance the individuals most likely to benefit from the treatment, and thus avoid treating those unlikely to benefit. [Rationed Health Care anyone?]

Lots more Mostly NIH and then this goodie:

38744 7/1/2006-4/30/2012

Bill & Melinda Gates Foundation

Vaccine Immunology Statistical Center (VISC) The VISC will provide 1) statistical and study design support for pre-clinical vaccine performance trials, 2) centralized data management services for the standardized evaluation of vaccine candidates, 3) development of new statistical methods for cross-species correlates-of-protection analysis.

Role: Faculty Statistician

BIBLIOGRAPHY Publications in Refereed Journals

1. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159(9):882-90.

2. Janes H, Pepe M, Kooperberg C, Newcomb P. Identifying target populations for screening or not screening using logic regression. Stat Med. 2005;24(9):1321-38.

12. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. HIV-1 vaccine-induced immunity in the test-of-concept Step study: A casecohort analysis. Lancet. 2008;372(9653):1894-905. PMCID: 2774110.

13. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design. J Natl Cancer Inst. 2008;100(20):1432-8. PMCID: 2567415.

21. Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study). J Acquir Immune Defic Syndr. 2011;57(3):238-44. PMCID: 3446850.

22. Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D, Duerr A. An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: Results from a randomized placebo-controlled trial (the Step study). J Infect Dis. 2011;203(6):765-72. PMCID: 3119328.

And many more. I am sure Fauci loves her.

……

Michael Kurilla, M.D., Ph.D.
Expertise: Infectious Diseases, Pathology
Director, Division of Clinical Innovation
National Center for Advancing Translation Sciences
National Institutes of Health

National Center for Advancing Translational Sciences

The National Center for Advancing Translational Sciences (NCATS) is one of 27 Institutes and Centers at the National Institutes of Health (NIH). The focus of NCATS is to advance the science of translation, which is the process of turning observations into interventions to improve health.
National Center for Advancing Translation Sciences

……

Myron Levine, M.D., D.T.P.H., F.A.A.P
Expertise: Infectious Diseases

Simon & Bessie Grollman Distinguished Professor
Associate Dean for Global Health
Vaccinology and Infectious Diseases Center for Vaccine Development
University of Maryland School of Medicine

Center for Vaccine Development and Global Health – UMB …

University of Maryland School of Medicine

For more than a year, researchers at the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) have been working tirelessly on COVID-19 research, helping to pave the way for the use of vaccines and therapies that are being administered across the country.
Under the leadership of CVD director Kathleen Neuzil, MD, MPH, FIDSA, the Myron M. Levine, MD, DTPH, Professor in Vaccinology at UMSOM, researchers quickly pivoted decades of vaccine and infectious disease research experience toward combating this deadly virus, which continues to impact millions of people around the world.
Faculty at CVD have served in critical leadership roles in U.S. and international research and policy efforts. For example, Neuzil co-chaired the COVID-19 Prevention Trials Network, a research network established by the National Institute of Allergy and Infectious Diseases [NIAID Dr. Fauciwas appointed director of NIAID in 1984.] in response to the pandemic. Vaccine research at CVD continues, with an emphasis on reaching the populations most impacted by COVID-19 and testing pediatric vaccines.
CVD experts have launched an expansive grassroots campaign to educate the community and reach those who have been hit the hardest by this terrible virus, including members of the Black and Brown communities, the elderly, and those with underlying health risks.
“Our CVD team has worked tirelessly and meticulously to advance COVID-19 vaccines and to ensure they are reaching the most affected populations,” Neuzil said. “Our work continues as we begin testing vaccines in children and investigate booster vaccines to address the risk of COVID-19 variants.” [Like this Dude is neutral?]

Center for Vaccine Development and Global Health (CVD …

Our research, surveillance and vaccine development focuses on four key areas: Enteric Diseases, Malaria, Influenza and Respiratory Diseases, and Emerging Pathogens.
Overview
Our faculty and staff are experts in the field of global health and vaccinology, and they are dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world. Our key mission is to harness the power of vaccines to prevent disease and save lives in the most vulnerable populations.

…….

H. Cody Meissner, M.D.
Expertise: Infectious Diseases
Professor of Pediatrics
Tufts University School of Medicine
Director, Pediatric Infectious Disease
Tufts Medical Center
POST GRADUATE TRAINING

1973 – 1975 Internship and Residency Boston Floating Hospital New England Medical Center Boston, MA

1975 – 1977 Research Associate Public Health Service National Institute of Child Health and Human Development National Institute (NICHD) Bethesda, MD Parent Agency is National Institutes of Health (Fauci)

2008 – Present Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)

2010 – Present Massachusetts Vaccine Purchasing Advisory Council

2017 – Present National Vaccine Advisory Committee, United States Department of Health and Human Services

2017 – Present Vaccine Injury Compensation Program, United States Department of Health and Human Services

AWARDS

Massachusetts 2017 Recipient of the CDC Childhood Immunization Award

The National Vaccine Injury Compensation Program: Striking a Balance Between Individual Rights and Community Benefit.

Meissner HC, Nair N, Plotkin SA. JAMA. 2019 Jan 29

The Importance of MMR Immunization in the United States.

Perrone O, Meissner HC. Pediatrics. 2020 Aug

Principles of Vaccine Licensure, Approval, and Recommendations for Use.

Pickering LK, Meissner HC, Orenstein WA, Cohn AC. Mayo Clin Proc. Epub 2020 Feb 13.

H. Cody Meissner, MD | Tufts Medical Center

H. Cody Meissner, MD, is a leading national expert on childhood vaccinations who consults with the Centers for Disease Control and Prevention on periodic updates to the recommended immunization schedule for newborns through 18-year-olds. At Tufts Children’s Hospital at Tufts Medical Center he heads the Division of Pediatric Infectious Diseases

….

Paul Offit, M.D.
Expertise: Infectious Diseases
Professor of Pediatrics
Division of Infectious Diseases
The Children’s Hospital of Philadelphia

Paul A. Offit, MD is the Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia as well as the Maurice R. Hilleman Professor of Vaccinology and a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, and a Research Career Development Award from the National Institutes of Health. Dr. Offit has published more than 160 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the coinventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC….
FDA

In 2017, Dr. Offit was a weekly columnist for The Daily Beast.

Papers:

2018

Plotkin, S.A., P.A. Offit, and P. Bégué, : “Vaccine mandates in France will save lives,” Science 359: 283-284, 2018.

Plotkin SA, Offit PA, Reiss D.: Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines. Pediatr Infect Dis J. 37(12), Dec. 2018.

To the Editors:

Vaccination is under attack by individuals who occasionally use the legal system to oppose mandatory vaccination laws and in some cases to obtain exemptions for particular children whose parents are opposed to vaccination. During the legal proceedings, as we have witnessed, experts testifying in favor of vaccination may be challenged with references from journals of doubtful quality that oppose vaccination.
To provide important references that discuss and disprove claims made against vaccines, the Vaccine Education Center at the Children’s Hospital of Philadelphia has created a library of references addressing certain safety issues that may be useful as an aid and refresher to clinicians giving expert testimony on the safety of vaccines and to lawyers defending vaccination of children.
The Children’s Hospital of Philadelphia legal library may be entered through the web address vaccine.chop.edu/safety-references.
We would be grateful if you could inform your colleagues about the availability of this resource, which should be of great value for experts testifying for vaccination and for clinicians who need to convince parents about vaccine safety. https://journals.lww.com/pidj/Fulltext/2018/12000/Important_New_Resource_for_Clinicians_Giving.42.aspx

2017

Offit, P.A.: “Commentary: Science Denialism Isn’t New to the Trump Administration,” Philadelphia Inquirer December 22 2017.

Offit, P.A.: “By Regulating Homeopathic Remedies, FDA Holds ‘Modern-Day Snake-Oil Salesmen’ Accountable,“ Philadelphia Inquirer December 28 2017.

2013

Williams SE, Rothman RL, Offit PA. Schaffner W, Sullivan M, Edwards KM. A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study. Academic Pediatrics (2013) 13: 475-480.

A look at his recent papers shows he is targeting vaccine hesitant parents.

https://pubmed.ncbi.nlm.nih.gov/?term=Offit+PA&cauthor_id=24011750&size=20

…..

Steven Pergam, M.D.
Expertise: Infectious Diseases
Medical Director
Infection Prevention
Seattle Cancer Care Alliance — Seattle, WA

He seems to specialize in cancer and immuno-compromised and seems to be the best of a bad bunch. But then we look at this:

SPECIAL NATIONAL RESPONSIBILITIES:

2009–2010 Independent Safety Monitor, NIH/NIAD, DMID Influenza Protocols: 09-0039, 09-0043, 09-0047, 09-0053, and 09-0054: H1N1

2010–2011 Independent Safety Monitor, NIH/NIAID, DMID Protocol 09-0002: Comparison of the Safety and Immunogenicity of Lyophilized IMVAMUNE® (1×108 TCID50) versus Liquid Formulation IMVAMUNE® (1×108 TCID50) Administered by the Subcutaneous Route and a Lower Dose Liquid Formulation IMVAMUNE® (2×107 TCID50) Administered by the Intradermal Route in Healthy Vaccinia-Naïve Individuals (Bavarian Nordic)

2011–2013 Member, Data and Safety Monitoring Board: Effect of tenofovir on genital HSV shedding: a randomized, double-blind, placebo-controlled, clinical trial

2015-present Member, Zoster Working Group, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention, Department of Health and Human Services

2016-present Member, Abstract Selection Committee, Association for Professionals in Infection Control and Epidemiology (APIC)

2016-2017 Independent Safety Monitor, NIH/NAID, DMID Protocol 16-0117: Comparison .of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients

15. RESEARCH FUNDING

Current: Washington Vaccine Alliance (WAVA) Pilot Award (PI: S. Pergam) 10/1/13-6/30/20 Interactions between gastrointestinal microbiota, Influenza vaccine responses and respiratory viral infections in a large cohort of clinic employees

BAA-NIAID [Fauxi Director]-DMID-NIH-AI (PI: M. Ison; Subcontract PI: Pergam) 5/1/16-4/30/20 Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients 1U01AI132004-NIAID (PI: N.Halasa; Subcontract PI: Pergam)

7/5/2017-6/30/20 High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients 1R01AI134808-NIAID (PI: D. Fredricks)

Completed:

NIH/NIAID T32 AI007-044 (PI: W. Stamm) 9/1/05-2/1/07 Host Defense Training in Allergy and Infectious Diseases

Industry Sponsored Clinical Trials:

Chimerix, Inc. (PI: Pergam) 2016-current An Intermediate-size, Expanded Access Protocol to Provide Bincidofovir for the Treatment of Serious Adenovirus Infection or Disease, Protocol CMX001-35”

6/17/2017-present Prior Industry Trials Merck, Sharp & Dohme Co., Inc (PI: Pergam)

2012-2015 Pergam, SA – CV Page 15 A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCT)

Cubist Pharmaceuticals, Inc.* (PI: Pergam) 2013-2015 A Phase IIIb, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study to Demonstrate the Safety & Efficacy of Fidaxomicin for Prophylaxis against C difficile-Associated Diarrhea in Individuals Undergoing Hematopoietic Cell Transplants (HCT) *formerly Optimer pharmaceuticals

KRT16/26/21, 01:40 PM

$ACXP In December 2014, Merck ($MRK) paid US$9.5 billion for Cubist ($CBST) largely to obtain marketing access to agents daptomycin and fidaxomicin. https://stocktwits.com/symbol/CBST

Chimerix, Inc. (PI: Pergam) 2016 A Multicenter Non-Interventional Study to Obtain Retrospective Data for Subjects Previously Diagnosed with Adenovirus Infection to serve as Matched Historical Controls for Study CMX001-304; Protocol No. CMX001-305

Chimerix, Inc. (PI: Pergam) 2015 – 2017 A Phase 3, Open-label, Multicenter Study of the Safety/Tolerability and Efficacy of Brincidofovir (CMX001) for the Prevention of Adenovirus (AdV) Disease in Subjects with Asymptomatic AdV Infection at Risk of Progression and for the Treatment of Subjects with Localized or Disseminated AdV Disease

Chimerix, Inc.

All that shimmers isn’t … enhanced by lipid conjugate technology. Chimerix is a development-stage biopharmaceutical company, dedicated to accelerating the advancement of innovative for patients living with cancer and other serious diseases. Its two clinical-stage development programs include dociparstat sodium (DSTAT) and brincidofovir (BCV). DSTAT, is a glycosaminoglycan derivative of heparin with known anti-inflammatory properties and BCV is an oral antiviral in development for the treatment of smallpox.

2505 Meridian Pkwy Ste 100 Durham, NC,

https://www.dnb.com/business-directory/company-profiles.chimerix_inc.a1878daaef1b59d25a1d2e8876c4b4bf.html

Chimerix, Inc.’s key principal is Michael A Sherman. Chimerix, Inc. has 54 employees

https://wallmine.com/people/8557/michael-a-sherman

…..

Jay Portnoy, M.D.
Expertise: Consumer Representative (This the guy who is supposed to represent the interests of the Public.)
Professor of Pediatrics
Medical Director of Telemedicine Section of Allergy, Asthma and Immunology
Children’s Mercy Hospital Kansas City, MO

Offices and Board of Directors:

American Board of Allergy & Immunology (ABAI). 2014-present.

Vice President, American College of Allergy, Asthma & Immunology 2005-6.

Board of Directors, Black Healthcare Coalition. 2006-2009. [He is WHITE]

Editorships and Editorial Boards

Regional Editor, World Allergy Organization Journal. 2008 to 2012.

Section Editor, Annals of Allergy and Asthma. Appointed 2002 to 2005

Editor, Current Opinion on Allergy & Asthma. Issue on Pediatric Allergy. 2004 and 2005

Editor, Current Allergy and Asthma Reports. Issue on Pediatric Allergy. 2001-2013

Editorial Board, Allergy Watch. 1998-2001.

Editorial Board, Annals of Allergy and Asthma. 1994 to 2006

Editorial Board, Current Allergy Practice. 1993 to present

Other Appointments

FDA advisory panel (CBER), Allergenic Extracts.

2017-present FDA advisory panel (CDER). Respiratory and allergy drugs.

2010-present FDA advisory panel (CBER), Allergenic Extracts.

2005-2010 Special Emphasis Panel. T-cell Epitopes. NIAID. 2011.

https://www.fda.gov/media/105541/download

The guy has 151 papers mainly dealing with allergy so I am not going to look at all of them.

He seems to work with Environmental Allergens Workgroup. Also with American College of Allergy, Asthma & Immunology – “…a professional medical association of more than 6,000 allergist-immunologists and allied health professionals…” He is a Fellow, American Academy of Allergy, Asthma, and Immunology (AAAAI) …. if you search long enough…. You find an AAAAI Legislative Action article urging Allergists to support Fauci’s funding.

NIAID, NIEHS, NHLBI, MCAN Workshop Report: The Indoor Environment and Childhood Asthma: Implications for Home Environmental Intervention in Asthma Prevention and Management

The National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Environmental Health Sciences (NIEHS), National Heart, Lung, and Blood Institute (NHLBI), and Merck Childhood Asthma Network (MCAN) sponsored a joint workshop to discuss the current state of the science with respect to the indoor environment and its effects…

Adverse reactions to vaccines practice parameter 2012 update

…..Thus although patients with a history of mild reactions to egg ingestion (hives only) can receive their vaccine in a primary care provider’s office, those with a history of more severe reactions (cardiovascular, respiratory, or gastrointestinal symptoms) should receive the influenza vaccine in an allergist’s office. In both cases, personnel to recognize and equipment to treat anaphylaxis need to be immediately available, but the allergist’s office affords additional expertise in this area should it be required…..
…..There has been a great deal of additional information published over the past year demonstrating the safety of influenza vaccination in patients with egg allergy. Health care providers should no longer withhold the vaccine from any patient with egg allergy. In an update to recommendations made in the last year, it is now considered safe for patients even with a history of a severe egg allergy to receive influenza vaccination…..

No worries, we will revive you when you almost die of anaphylaxtic shock, it is utmost importance for us to jab you with a shot that is probably useless so we can get paid our bonus.
…..

Andrea Shane, M.D., M.P.H., M.Sc.
Expertise: Pediatric & Infectious Diseases

Professor of Pediatrics
Director Division of Pediatric Infectious Diseases
Emory University School of Medicine – Atlanta, GA

Joint appointment:
Assistant Professor of Global Health Hubert Department of Global Health, Rollins School of Public Health, Emory University 01 September 2013-present

Military or Government Service: Lieutenant Commander, United States Public Health Service, 2001-2003; Inactive Reserve Corps (IRC) 2003-until IRC dissolved in 2010.
……
The United States Public Health Service is a collection of agencies of the Department of Health and Human Services concerned with public health, containing eight out of the department’s eleven operating divisions. The Assistant Secretary for Health oversees the PHS.
WIKI

ALSO:

OASH oversees the Department’s key public health offices and programs, a number of Presidential and Secretarial advisory committees, 10 regional health offices across the nation, and the Office of the Surgeon General and the U.S. Public Health Service Commissioned Corps. https://www.hhs.gov/ash/index.html
……

Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices (ACIP) respiratory syncytial virus (RSV) immunoprophylaxis working group, appointed member, 2009-until committee dissolved by CDC in 2011.

Infectious Diseases Society of America (IDSA) National Global Public Health Committee (NGPHC), appointed member 2010-2013.

World Society of Pediatric Infectious Diseases (WSPID), Board Member and member of the Education Committee representing the Pediatric Infectious Disease Society (PIDS), appointed 2017; term through 2019.

[THIS IS WHERE SHE HAS A LOT OF POWER]
Manuscript reviewer:
American Journal of Infection Control, 2001-2003
Clinical Infectious Disease Journal, 2003-present
Journal of Infectious Diseases, 2003 – present
Pediatrics, 2006 – present
Journal of Pediatrics, 2006-present
The Pediatric Infectious Disease Journal, 2003-present
Infection Control and Hospital Epidemiology, 2003 – present
Archives of Pediatrics and Adolescent Medicine, 2006 – present
Emerging Infectious Diseases Journal, 2006 – present
Neonatology, 2008 – 2010
Journal of American Medical Association, 2009 – present
JAMA Pediatrics, 2013 – present
Journal of Pediatric Infectious Diseases, 2013-present
Pediatric Research 2017-present
Clinical Therapeutics, 2017-present
Faculty of 1000 (f1000), Public Health and Epidemiology section, post publication peer review of publications, 2009 -2011. [WTF???]
Pediatric Infectious Disease section with creation of the section, 2011-2014.

Honors and Awards:
International exchange fellowship, Children’s Hospital at Montefiore and Beijing Children’s Hospital, Beijing, China October-November, 1999

Department of Health and Human Services, Public Health Service Crisis Response Service Award, 2002

Department of Health and Human Services, Public Health Service Outstanding Unit Citation, 2002

National Foundation for Infectious Diseases (NFID) Advanced Vaccinology Course Travel Grant to attend ADVAC 9, Annecy, France, 2008

National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, Special Recognition, H1N1 influenza research, 2010

Center for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases Award for Excellence in Partnering-Domestic to NETEC (the National Ebola Training and Education Center)…. This award recognizes programs’ initiative and effectiveness through establishing and sustaining a strategic partnership with government, private sector, volunteer, or nonprofit organizations, 24 March 2016.

Contracts:

Co- investigator, NIH/NIAID/DMID Vaccine and Treatment Evaluation Unit (VTEU) – Emory University School of Medicine. Role: Site PI on rotavirus vaccine cross-over trial, DMID #08- 0017 and influenza vaccine to breastfeeding women trial, DMID#09-007; site co- investigator on other trials. Salary support, 01 August 2007- 01 August 2016….

………….

Paul Spearman, M.D.
Expertise: Pediatric & Infectious Diseases

Director, Division of Infectious Diseases
Albert B. Sabin Chair in Pediatric Infectious Diseases
Cincinnati Children’s Hospital Medical Center
Professor, Department of Pediatrics
University of Cincinnati School of Medicine Cincinnati, OH

This guy is a really big heavy weight. There is cross-over with the lady, Andrea Shane above. Any bets he pulled her in to be his ‘female puppet’ – a good little government soldier?

11/2005-09/2016: Professor and Division Director Nahmias-Schinazi Research Chair Pediatric Infectious Diseases Department of Pediatrics Emory University School of Medicine
11/2005-09/2016: Associate Director for Pediatric Studies Emory Vaccine Center Atlanta, GA
03/2009-09/2016: Vice Chair for Research Department of Pediatrics Emory University School of Medicine
03/2009-09/2016: Chief Research Officer Children’s Healthcare of Atlanta Atlanta, GA

[Andrea L. Shane is Attending Pediatrician Children’s Healthcare of Atlanta Emory Healthcare Grady Health 01 August 2006 – present ]

This guy has a full page of
COMMITTEE MEMBERSHIPS:
a. National and International:

NIH Councils and Study Sections Chair, NIH ZRG1 AARR-E (41)
December 2016 Member, NIH ZRG1 AARR-P (02)
December 2016 Chair, NIH SEP: ZRG1 AARR-K (02)M; AIDS and related research SEP
August 2016 Chair, NCI Board of Scientific Counselors, Site Visit Team, Review of HIV DRP, Frederick, MD
July 2016 Chair, NIH SEP: ZDE1; Approaches to Eliminate HIV and Opportunistic Pathogens from Oral Reservoirs
November 2015 Chair, NIH SEP: ZRG1 AARR-E; AIDS and AIDS-related
July 2015 Chair, NIH SEP: Basic Research on HIV Persistence
March 2015 Chair, NIH/NIDCR Review Panel on HIV and Oral
March 2015 Opportunistic Pathogens
.
.
.

NIH/NIAID HIV Vaccine Trials Network
Protocol Chair, HVTN 088 Protocol 2010-present
Chair, Chiron/Novartis Products Development Team 2000-2007
Chair, Wyeth Products Development Team 2001-2007 Protocol
Chair, HVTN 049 Protocol 2002-2007 Protocol
Chair, HVTN 056 Protocol 2002-2006 Protocol
Chair, HVTN 061 Protocol 2003-2005 Member, HVTN Phase I-II Committee 2002-2005 Protocol
Chair, HVTN 088 Protocol 2010-present
NIH/NIAID/DMID Vaccine and Treatment Evaluation Unit Co-Principal Investigator, Emory VTEU site 2007-present
Protocol Chair, VTEU 0008 Protocol 2009-2014
NIH/NICHD-Westat/NIAID IMPAACT Network Principal Investigator, Emory IMPAACT site 2014-present
.
.
.
CONSULTANTSHIPS:
Chiron, HIV Vaccines Development Team, Emeryville, CA 2003, 2004
Wyeth, HIV Vaccine Programs, Pearl River, NY 2003, 2004

EDITORSHIPS AND EDITORIAL BOARDS: [Again this is where a lot of power lies.]
Member of Editorial Board, Journal of Virology
Member of Editorial Board, Virology
Member of Editorial Board, Current HIV Research
Academic Editor, PLoS One

MANUSCRIPT REVIEWER: [There is that POWER again]
Journal of Virology (numerous, 1995-present)
Virology (numerous, 1998-present)
Current HIV Research (2001-present)
Ad Hoc reviewer, Biochemistry (2005, 2006)
Ad Hoc reviewer, Traffic (2005, 2006, 2007, 2013)
Ad Hoc reviewer, JAIDS (2004, 2011, 2012, 2013, 2014, 2015)
Ad Hoc reviewer, JBC (1997-present)
Ad Hoc reviewer, Leukocyte Biol (2000)
Ad Hoc reviewer, Vaccine (2000-2016)
Ad Hoc reviewer, Virus Research (2005, 2012, 2012, 2013)
Ad Hoc reviewer, Nature Structural Biology (2005)
Ad Hoc reviewer, PLOs Medicine (2006, 2007, 2008)
Ad Hoc reviewer, J Mol Biol (2007,2012, 2015, 2016)
Ad Hoc reviewer, PNAS (2007, 2008, 2009,2012, 2013, 2014)
Ad Hoc reviewer, JCB (2007, 2008, 2010, 2011,2012, 2013)
Ad Hoc reviewer, PLOs One (2008, 2009, 2010,2011,2012, 2013, 2014) 6
Ad Hoc reviewer, Cell Host and Microbe (2008-present)
Ad Hoc reviewer, Nature Medicine (2009, 2011,2012, 2016)
Ad Hoc reviewer, PLOs Pathogens (2009-present) Ad Hoc reviewer, J Immunology (2010, 2011, 2013) Ad Hoc reviewer, Retrovirology (2011-present)
.
.
GRANT SUPPORT:
a. Active Support

Federally funded:
NIH R01 AI058828: Role of Vpu in HIV Particle Assembly. Funded since 2004, currently in no-cost extension with competing renewal under review.
NIH R01 GM111027-17A1: Viral and Cellular Determinants of HIV-1 Assembly. Funded 9/16/2013-8/31/2017 (Principal Investigator). $200,000 initial period; $800,000 direct costs.
NIH R01AI11863: Mucosal Protection against HIV Generated by PIV5 Priming and VLP Boosting. Funded 4/01/2014-8/31/2018 (Principal Investigator, Multiple PI grant). $351,366/yr.
Private foundation funded:
None presently.
Industry Contracts:
None presently

b. Previous Support:
NIH R01HL125042: HIV-induced Redox Stress and the Alveolar Macrophage as a Resistant Reservoir. Funded 7/01/2014-6/30/2018 (Principal Investigator, Multiple PI grant). $686,584/yr; relinquished upon relocation to Cincinnati.
NIH K12 HD072245: Atlanta Pediatric Scholars Program. Funded 04/01/2011-11/30/2016 (Program Director). $324,000/yr.
HHSN275201300003C: Westat/NICHD Contract- IMPAACT Network; Pediatric and Adolescent HIV/AIDS Research Program at Emory University. Funded 9/01/2014-8/31/2019 (Site Principal Investigator). $450,000/yr estimated.
NIAID-DMID-NIH AI2012144: Vaccine and Treatment Evaluation Units (VTEU). Funded 9/13/2013-9/12/2020. (Co-Principal Investigator). $4-5M/yr estimated. 8
NIH R21 AI098592: HIV-specific B cell repertoire in humans following cross-clade immunization. Funded 7/01/2012-6/30/2014 (Principal Investigator). $150,000 initial period; $275,000 direct costs.

NIH R01 AI090656: Broadly-reactive antibodies against chimeric virus-host antigens. Funded 06/14/2010-05/31/2014 (Co-investigator).

I wonder if he knows Ralph Baric??

NIH U01 AI069418: HIV/AIDS Clinical Trials Unit. Funded 2/01/2007-11/30/2013 (Coinvestigator). HHS N272200800005C: Vaccine and Treatment Evaluation Units. Funded 11/01/07- 10/31/14 (Co-Director), $2,494,361/yr.
NIH U01AI78407 : Clonal Analysis of the Human B Cell Response to HIV. Funded 2/01/08-01/31/13 (Co-Investigator), $150,000/yr (Emory component); $750,000 total.
NIH RO1 AI40338: Viral and Cellular Determinants of HIV-1 Assembly. Funded since 1994; (Principal Investigator). $250,000 initial period; $1,150,000 total- now transitioned to GM111027 (active, above).
NIH R01 CA27834: Genetics of Primate “D” Type Retroviruses. Funded 09/24/07- 11/30/12 (Co-investigator), $250,000/yr, $1,250,000 total.
NIH R01 AI084834: Defining Neutralization Breadth in HIV-positive serum. Funded 9/01/2009-8/31/2011 (Principal Investigator), $250,000 initial period, $500,000 total.

NIH R21 AI65312: Pseudovirion Formation by Live Vector HIV Vaccines. Funded 06/01/2006-05/31/2008 (Principal Investigator), $150,000 initial period; $300,000 total.

NIH R01 AI067101: Novel Assays for Inhibitors of HIV Assembly. Funded 6/15/2005- 5/31/2008 (Principal Investigator), $200,000 initial period; $550,000 total.
NIH U01 AI47985: HIV Vaccine Trials Units. Funded 06/00-05/05. $1,438,628 initial period; $7,637,877 total.
NIH P30 AI054999: Vanderbilt-Meharry Developmental CFAR. Funded 05/01/03-04/30- 06 (Co-investigator), $528,468 initial period; $1,633,442 total.
NIH R29 AI40338-01A1: Membrane Binding and Transport of HIV-1 Pr55Gag. Funded 03/97-03/2002 (Principal Investigator). $ 70,000/ year; $350,000 total.
NIH R21 AI44369 (Innovation Grant): Development of Enhanced HIV-1 Pseudovirion Vaccines. Funded 07/99-06/01(Principal Investigator). $140,000/ year; $260,000 total.
NIH R55 CA83527-01A1: Induction of KSHV replication by HIV-1. Funded 03/00-02/02 (Principal Investigator). $80,000 total.
.
.
.
NIH R01 AI52007: Development of Enhanced HIV-1 Pseudovirion Vaccines. Funded 06/2002-05/2007 (Principal Investigator), $225,000 initial period, $1,125,000 total.

NAI113678, GlaxoSmithKline: An open-label, multicenter, single arm study to evaluate the safety and tolerability of intravenous zanamavir in the treatment of hospitalized adult, adolescent, and pediatric subjects with confirmed influenza infection. Funded 10/02/12- 05/01/15. Principal Investigator.
P903-23, Cerexa: A multicenter, randomized, observer blinded, activ-controlled study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of ceftaroline vs. comparator in pediatric subjects with acute bacterial skin and skin structure infections. Funded 01/01/2013-12/31/2014. Principal Investigator.
Merck Contract: Protocol 007: A Probe Study of the Safety, Tolerability, and Immunogenicity of a Three-dose Regimen of the Ad5 Gag Vaccine in Healthy Adults. Funded 04/01-12/02, $113,000 total (Principal Investigator).
Merck Contract: Protocol 012: A Probe Study of the Safety, tolerability, and Immunogenicity of the Ad5 HIV-1 Gag Vaccine. Funded 07/01/01-06/30/2003, $114,000 total (Principal Investigator).
Merck Contract: Protocol 016: A phase I dose-ranging study of the safety, tolerability, and immunogenicity of the Merck trivalent adenovirus serotype 5 HIV-1 gag/pol/nef vaccine in a prime-boost regimen in healthy adults. Funded 05/01/03-04/30/05, $117,000 total.
Basic Research Grant, Elizabeth Glaser Pediatric AIDS Foundation: Pseudovirion formation by live vector HIV vaccines. Funded 03/01/02-02/28/2004, $180,000 total.
.
.

LECTURESHIPS, SEMINAR INVITATIONS, AND VISITING PROFESSORSHIPS:
.
.

Invited speaker, Peking University Department of Biomedical Engineering, Beijing, May 2015: “HIV-1 replication in macrophages”
Invited speaker, Chinese Academy of Sciences, Institute of Biophysics, Beijing, May 2015: “Intracellular trafficking of the HIV envelope glycoprotein”

…………

Geeta K. Swamy, M.D.
Expertise: Infectious Diseases

Senior Associate Dean Vice Chair for Research & Faculty Development
Associate Professor, ObGyn
Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine
Duke University, Durham, NC

2004 – 2006 Duke University Associate Faculty Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine & Division of Clinical & Epidemiological Research

2009 – present Duke University Vaccine Trials Unit Investigator Duke Translational Research Institute Durham, NC

2010 – 2018 Duke University Director Duke Perinatal Research Center Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine Durham, NC

2012 – present Duke University Associate Professor Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine & Durham, NC

2013 – present Duke University Human Vaccine Institute Investigator Durham, NC

2016 – 2017 Duke University Associate Dean for Regulatory Oversight & Research Initiatives in Clinical Research Durham, NC

Professional Awards and Special Recognition

2008 NIH Young Investigator Award Perinatal Research Society Meeting, Santa Fe, New Mexico
2010 NIH – NIAID Special Recognition for H1N1 pandemic
2013 and 2014 “Outstanding Reviewer” (Top 10%), Obstetrics and Gynecology
2014 “Outstanding Reviewer” for Vaccine

RESEARCH

Active Grants:
NICHD Maternal-Fetal Medicine Research Units (MFMU) 4/7/11 – 3/31/21

NIH-NICHD (Swamy) Principal Investigator Participation as a clinical site in the NICHD sponsored MFMU Research Network to investigate treatment strategies for common yet unresolved obstetric conditions through large multicenter collaborative trials

Past Grants:
Health Works for Women, NIH Summer Research Fellowship, University of North Carolina at Chapel Hill, Center for Health Promotion & Disease Prevention, 1994

PiiiTCH Study-Prevention of Influenza in Infants by Immunization of Their Household Contacts (CDC, Walter) Co-Investigator

NIH-NIAID (HHSN272200800057C, Swamy) Duke Site Principal Investigator
Randomized, Double-Blind Trial on Safety & Immunogenicity of Inactivated Trivalent Influenza Vaccine in Pregnant Women

NIH-NIAID (HHSN272200800057C, Swamy) Duke Site Principal Investigator A Phase II Study in Pregnant Women to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Inactivated Influenza Vaccine Administered at Two Dose Levels

GlaxoSmithKline (Swamy) Cost-effectiveness of seasonal influenza vaccination during pregnancy An epidemiological study to develop and validate a model for estimating the costs and outcomes related to seasonal influenza vaccination during pregnancy for both mothers and infants through age 6 months.

Charles Hammond Research Fund (Gray) Mentor Assessing Decision Making & Acceptance of H1N1 Influenza Vaccine Administered in a Research Setting In Pregnancy

CDC-NCIRD – 1U01IP000190-01 (Swamy) Principal Investigator Effectiveness of a Vaccination Program in the Community ObGyn Setting The main objective of this 2-year project is to conduct a clinic-based study to develop and assess the effectiveness of a vaccination program for adolescent and adult women in the community Ob/Gyn setting.

ACOG/Merck & Company Research Award on Immunization (Fortner/Swamy) Mentor/Principal Investigator Compliance with Vaccination in the Obstetrical Setting with Novel H1N1 and Seasonal Influenza Retrospective review of births occurring in Durham, North Carolina during the 2009-2010 influenza season to evaluate influenza vaccination practices during the novel H1N1 pandemic.

Charles Hammond Research Fund (Swamy) Principal Investigator Association of Circulating Mitochondrial DNA Content and Preterm Birth Among Black Mothers

NIH-NIAID (HHSN272200800057C, Swamy) Duke Site Principal Investigator A Randomized, Double-Blind Trial on the Safety and Immunogenicity of Seasonal 2010-2011 Inactivated Trivalent Influenza Vaccine in Pregnant Women
.
.
Vaccine & Treatment Evaluation Units 9/16/13 – 9/15/23
NIAID (HHSN272201300017I, Walter and Swamy)
Co- Principal Investigator Participation as a clinical site in the NIAID sponsored VTEU Network to conduct clinical trials of vaccine and treatments for infectious diseases

Contract PI for the following active trials
 A Phase I, Double-Blind, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 vs Placebo Administered Intravenously in Healthy Adults

 Group B Streptococcus (GBS) Colonization and Disease Among Pregnant Women: A Historical Cohort Study

 A Phase I Cohort-Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants: Assessment of Immunological Responses and Lymphocyte Interplay

 A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis

 A Double Blind, Randomized, Placebo-Controlled, Phase I Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, Hydro Vax-001, in Healthy Adults

 An Opportunistic Study to Evaluate the Population Pharmacokinetics of Beta-lactam Antibacterials in Adults Including Elderly Subjects (POPS_SILVER)

 A Population Pharmacokinetic Study to Evaluate Disposition of Azithromycin and Ertapenem in Pregnant Women Undergoing Cesarean Delivery After Failed Labor (POPS_CAN_DO)

 Targeted Reduction of Antibiotics Using Procalcitonin in a Multi-center, Randomized, DoubleBlinded, Placebo-Controlled Non-Inferiority Study of Azithromycin Treatment in Outpatient Adults with Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin (PCT) Level of ≤0.25 ng/mL (TRAP-LRTI)

Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a RSV F Nanoparticle Vaccine with Aluminum in Healthy 3rd Trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in their Infants Novavax, Inc. (Swamy) 12/1/15 – 7/31/19

Principal Investigator Clinical Immunization Safety Assessment (CISA) 9/29/15 – 9/28/18 Clinical Study of the Safety of Simultaneous Administration of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) and Inactivated Influenza Vaccine (IIV) in Pregnant Women CDC (HHS200-2012-53663, Swamy) Principal Investigator
.
.
.
GlaxoSmithKline Speaker Services, 2009 – 2012

NIH-NIAID Division of Microbiology & Infectious Diseases Working Group on the Enrollment and Safety Assessments of Pregnant Women in Clinical Trials of Drugs and Vaccines, 2010 to 2015

National Vaccine Advisory Committee – Maternal Immunization Working Group – 2014 to 2016

Appointed Member, February 2017 to present
HPV Working Group, February – June 2018

Consultative Workshop on Immunology Research Gaps Related to Maternal Immunization – Bill & Melinda Gates Foundation, May 25-26, 2015

WHO Brighton Collaboration Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) – Chair, Fetal Distress Working Group – 2015

Independent Data Monitoring Committee, GlaxoSmithKline, Inc. – RSV vaccines for the protection of children, 2015 to 2017

Data Safety Monitoring Board, Randomized Controlled Trial of Influenza Vaccine and Meningococcal Vaccine in Pregnant Malian Women and Their Infants Up To 6 Months of Age, Sponsor: Bill & Melinda Gates Foundation, 2011-2016

………….

Gregg Sylvester, M.D., M.P.H. +
Expertise: Alternate Industry Representative

Vice President – Medical Affairs
Seqirus Inc., Summit, NJ

Physician | Public Health Expert
Pharmaceutical Executive Expert in vaccine preventable diseases, pediatrics and population health.

Career Highlights
• Head of Medical Affairs for Seqirus, a CSL company
• Launched Pfizer’s Pediatric and Adult Pneumococcal conjugate vaccine, as well as Meningococcal B vaccine in the USA
• Launched Merck’s HPV4 vaccine in over 100 countries, presented to numerous National Immunization Technical Advisory Groups (NITAGs), public health and medical societies
• Partnered with community organizations in Delaware to reduce infant mortality, teen pregnancy rates and HIV rates

Professional Experience
SEQIRUS, a CSL company Summit, N.J Vice President, Medical Affairs 2016 – present
• Responsible for the strategy and implementation of Medical Affairs plan
• Ensures appropriate use of Seqirus’ influenza vaccines
• Overseas Phase IV research and presents data to NITAGs and other key stakeholders.

PFIZER VACCINES Collegeville, Pa
Vice President, Medical and Scientific Affairs: Americas 2013 – 2016
• Spearheaded science-based rationale to preserve Prevnar 13 infant schedule in US recommendations
• Successfully achieved an adult Prevnar 13 recommendation from US Advisory Committee on Immunization Practice
• Accelerated launch of groundbreaking Meningococcal B vaccine to accommodate urgent public health need

Global Head of Medical Affairs for Pediatric Vaccines 2010 – 2013
• Global Medical Lead for Pfizer’s Pediatric vaccine, Prevnar 13
• Created medical strategy for Prevnar 13, an asset exceeding over $5 billion in revenue
• Created innovate systems to improved scientific exchanges in a complex, global environment

MERCK VACCINES West Point, PA
Global Head of Medical Affairs for Adolescent Vaccines 2005 – 2010
• Created the medical affairs strategy for Merck’s HPV4 vaccine, Gardasil
• Spokesperson for all Merck vaccines
• Traveled extensively throughout the world presenting to governmental officials, regulatory agencies and public health/medical congresses

CHRISTIANA CARE HEALTH SYSTEM Greenville, DE
Medical Director, Eugene DuPont Preventive Medicine & Rehabilitation Institute 2001 – 2005
• Led Preventive Medicine for Delaware’s largest health care organization
• Expanded the community-based health programs, serving more than 50,000 people/year

DELAWARE HEALTH & SOCIAL SERVICES New Castle, DE
Cabinet Secretary 1997 – 2001
• Reported directly to Governor of the State of Delaware
• Managed the largest state agency, with more than 5,000 employees and an operating budget of ~$1 billion
• Implemented Medicaid Managed Care and Children Health Insurance Program (sCHIP) in Delaware State

Health Officer 1995 – 1997
• Led Delaware’s Public Health Division
• Formulated Public Health policies and supervised programs addressing high infant mortality rates, teen pregnancy rates, and low childhood immunization rates
• Promoted to Cabinet Secretary within one year

Chief of Community Health & Director of Maternal & Child Health 1993 – 1995
• Directed the development and implementation of community-based public health programs for the state of Delaware
• Managed an annual budget of $30,000,000 and 330 public health professionals

Selected Board Positions
IMA World Health: Chairman of the Board: 2017-2018;
Board Member: 2013 – present

DONORS: The majority of IMA World Health’s projects are funded through grants from generous public funding agencies and foundations.
CORUS INTERNATIONAL
◦ IMA World Health | Corus World Health
◦ Lutheran World Relief
◦ CGA Technologies ==> https://www.cgatechnology.com/
◦ Ground Up Investing
◦ LWR Farmers Market Coffee

Selected Honors and Awards
Merck Global Human Health Awards – 2007 & 2006 Winner: Franchise of the Year; 2006 Winner: Best Support of International Markets and 2008, 2007 & 2006

Education & Training Fellowships:

Public Policy – Joseph P. Kennedy, Jr. Foundation, assigned U.S. Senate, Washington, DC
Epidemic Intelligence Service – Centers for Disease Control & Prevention, Atlanta, GA
General Preventive Medicine Resident – Johns Hopkins School of Hygiene and Public Health, Baltimore, MD
Pediatric Intern, Resident and Chief Resident – Children’s Hospital of Buffalo – State University of New York at Buffalo School of Medicine, Buffalo, NY
Master of Public Health – Johns Hopkins School of Hygiene and Public Health, Baltimore,
MD Doctor of Medicine – Albany Medical College, Albany, NY
Bachelor of Arts – (History) – Ithaca College, Ithaca, NY
Veteran Status Commissioned Officer, United States Public Health Service: Rank – Commander – 1990 -1993

Summary

These are the people who have no problem giving an unvetted vaccine to children and pregnant women before the safety data is available. After all, they have been doing it on a smaller scale most of their careers.

-Gail Combs

GC/wm (written/edited)

The “Thalidomide Janet” Honorary List Of Mandate Nazis To Boycott

We need a place to keep track of who will be the recipients of our legally protected civil disobedience.

I am not saying how people should protest. Not doing business with these companies is a first step. Beyond that, consult your conscience.

Please add in the comments ANY businesses which require vaccine passports, or who require their employees, students, customers, or anybody else to be vaccinated.

I will keep a LIST up top, alphabetized, of who deserves to have their businesses destroyed.

This list is named in honor of Janet Woodcock, who helped the ChiNazis and Big Pharma addict Americans, before the Holderites turned on their evil partners and shook them down. SHE is the one who approved TWO of the deadliest drugs in FDA history – KNOWINGLY.

I should really call her “OxyContin Janet”, but failure to approve thalidomide (molecule on the left of the header, one of which mirror image forms causes birth defects) was once the FDA’s “point of pride”, and I think it’s a better millstone to hang around her neck. But many would argue that oxycodone (molecule on the right) is an even bigger crime. And if neither of those fits, try China’s favorite poison for Americans – fentanyl. Yes – she approved that one, too, although doctors do love it for surgery, so it’s a bit more legitimate.

In any case, Woodcock’s clearly political approval of the Pfizer DEATH JAB, in an obvious plot to poison America’s entire military on behalf of China, is enough for me to name this list after her.

Thank you for your suggestions!

W

THE LIST OF MANDATE SHAME

Amtrak

Anthem

Apple

Ascension Health

BlackRock

Centene Corporation

Chevron

Cisco

Citigroup

Clayton Homes (Warren Buffett)

CNN

CVS Health

Deloitte

Delta Airlines

Disney

DoorDash

Duke University

Durst Organization

Envision Healthcare

Equinox

Facebook

Ford

Frontier Airlines

Gilead Sciences

Goldman Sachs

Google

Hawaii Airlines

Hess

Jefferies

Johnson and Johnson

Lyft

McDonalds

Metro

MGM Resorts

Microsoft

Moderna

Morgan Stanley

NBC Universal

Netflix

New Mexico State University

New Orleans Saints

New York City

New York State

New York Times

Northwestern Mutual

Norwegian Cruise Line

Pfizer

Philadelphia School Board

Politico

Qantas

Quinnipiac University

Saks

Salesforce

TJX

Twitter

Tyson Foods

Uber

Union Square Hospitality Group

United Airlines

University of Virginia

UPS

ViacomCBS

Walgreens

Walmart

Warren Buffett (Clayton Homes)

Washington Post

Seeking Clarity on the Claim: 45,000 Dead Within Three Days of a COVID Vaccination – Plus an Amazing Analysis from a QAnon Standpoint

OK, people – I want to get clarity on this claim of the “45K whistleblower”. This is a good way for SCIENCE to cut around a lot of bullshit, if what I think is going on here, is actually going on here. This would be a huge bombshell that would basically destroy the medical deep state, if the science is explained properly. And then there is something else that I found, that is the strongest HOPANYL I have yet seen. This is almost carhopanil.

Part A – The Claim and Clarity – Help Requested

Here is the UGETube video of the FULL initial announcement of the whistleblower. I suggest opening in a new tab – you may not want to watch the full thing, if you are looking for hard data.

LINK: https://ugetube.com/watch/45-thousand-dead-whistleblower-alleges-massive-coverup-of-covid-jab-death-numbers_cCNAorLOt2i8SJQ.html

You will note that these are UGETube videos that – on some systems – will “autoplay”, and thus I’m only giving links.

What I want is to find exactly what this whistleblower is reporting. I think I understand it, and it will be EXPLOSIVE if the SCIENCE is framed correctly, which I can do. Sadly, I think this dude’s announcement to this church group was more framed in terms of emotion and “advertising” to his audience.

SO – please – in the comments – bring me ANYTHING you can find which sheds light on the SPECIFICS of the whistleblower claim.

Part B – Amazing Q Delta, Trump, Flynn, MAGA

Now, here is a different link on UGETube which includes a small portion of the above, but puts it in context of another “drop”, which was the FDA censoring one of it’s own presentations by hiding a power-point slide of vaccine side-effects. Clearly the FDA speaker was told at the last minute not to show the slide. It’s really worth watching that point, around 6:30 in the following presentation.

BUT WAIT – there’s MOAR. At 12:00 there is a MIND-BLOWING delta on a Q drop 1929 on July 20, 2018, that basically describes what the DS did in 2016 as “Movie 1”, then what was coming in Fall 2018 as “Movie 2”, and “Movie 3” “TBA”. First watch here, then the Q drop itself.

LINK: https://ugetube.com/watch/45-000-vaccine-deaths-whistleblower-expert-insider-testimony-people-need-to-go-to-jail_vDY55Gm9CfExoZ1.html

1929
Aug 20, 2018 12:02:47 AM EDT
Q !!mG7VJxZNCI ID: 000000 No. 170
[MOVIE 1]
Showtime.
BO>>CS>>BO>>NO>>CS>>NO>>BO>>[ ][ ][ ][ ][ ][ ]
Who instructed the DOJ to release ‘select’ text messages?
When did [RR] learn of involvement [BO][NO]?
What happens if [RR] knew PRIOR TO signing CP FISA?
Why did [RR] under congressional testimony refuse to answer the question re: reading of FISA prior to execution?
Who signed pg 380?
Who signed pg 389?
Who signed pg 390?
Who signed pg 391?
Who signed pg 392?
https://vault.fbi.gov/d1-release/d1-release/view
Who is [1 of 4] FIREWALLS?
Who signed?
FIREWALLS?
Who signed?
FIREWALLS?
FISA [20]
The ‘TRILOGY’.
MOVIE 1 [Full]: The ‘START’
PLOT: How the intelligence apparatus, State Dept, and Dept of “JUSTICE” of the United States, in joint effort w/ our (x) primary foreign allies + other covert assets, as directed by HUSSEIN [WH] in coordination w/ HRC, colluded and conspired to RIG THE PRESIDENTIAL ELECTION OF 2016 in an effort to install HRC, frame POTUS (PROJECTION!), create emergency contingencies re: installation of SAFEGUARDS and FIREWALLS to PREVENT EXPOSURE OR CONTINUATION OF PRESIDENCY SHOULD COUNTER FAIL TO ENSURE OPERATORS, ACTORS, AGENTS OF POWER, PAST & PRESENT, REMAIN IN CONTROL, AND USE SOURCES/COVERT ASSETS OF THE FAKE NEWS MEDIA TO CARRY OUT X-FRAME BARRAGE OF STRATEGIC COORDINATED [GUIDED] ATTACKS DESIGNED TO DIVIDE, COVER/SHELTER, JUSTIFY IMPEACHMENT/REMOVAL IN EFFORT TO REGAIN CONTROL AND PREVENT PUBLIC AWARENESS OF ILLEGAL, CRIMINAL, TREASONOUS ACTS [MOVIES 1-3 FULL LIST].
Coming SOON to a theater near you.
MOVIE 2 – Coming this FALL.
MOVIE 3 – TBA
Enjoy the show.
Q

From there, it gets into very timely postings by Trump, Flynn and others. Flynn’s Telegram posting is particularly interesting.

Trump’s statement is at 17:00 – Flynn’s is at 18:00.

I personally don’t focus on the “delta” as a proof, as much as serving as a vehicle to let you know that there are good people out there – we are not alone. Watch especially how Flynn is calling for people to blow the whistle or “come clean” before it’s too late.

Then, the remainder of the video goes to scripture – good stuff!

Remember that there is information warfare, but there is also spiritual warfare.

SPIRITUAL ARMOR will protect you in the INFORMATION BATTLE.

SEEK TRUTH, THE WHOLE TRUTH, AND NOTHING BUT THE TRUTH.

First of a four part series on the ongoing attack on the American Food Supply including a time line.

The Pub is OPEN!

And we’re finally serving a NORMAL DRINK tonight. Even though it’s a SECOND ROUND.

STAY TUNED…..

and what time of year is it now???

Christmas Spirit

And now, the rules of the pub.

HOUSE RULES

AMEN!

Free the January Brothers!

Current Art On The Wall

COVID-19 Vaccine Interference With AIDS and Syphilis Tests

Moscow Mule Revisited

Sipping This Popular Cocktail Is a “Health Hazard,” Experts Say

Failure of Socialized Science and Peer Review Exposed in a JAMA-Published Ivermectin Study

“New JAMA paper show Ivermectin blows the COVID vaccines out of the water”

YUP.

The data LITERALLY justify our position.

It wants the TRUTH.

ENJOY THE SHOW.

W

Use USA LAW!

-GC

Newly Uncovered COVID Vaccine Contracts Lead Unexpectedly to Academic Corruption and Shill Science Attacks on Honest, Skeptical Scientists

A Gail Combs deep dive into a tangent of Karen Kingston’s latest revelation on Pfizer Comirnaty vaccine deaths and injuries, leads back to the war against truth-telling doctors and scientists – this time by their own CORRUPT university employers.

PREFACE by Wolf Moon

START HERE….

So who is BARDA?

And that brings me to the digging I have been doing.

August 2, 2021

Sidebar by Wolf – Dr. McCullough on Stew Peters

Dec 20 2021

June 8, 2021

NIH Clinical Trials Baylor: LINK

484 ACTIVE Studies found for: Baylor College of Medicine | Recruiting, Enrolling by invitation Studies

So is there a Robert Atmar – Hana El Sahly connection???

2022 Jan 26.

2022 Jan 26.

2021 Oct 15

EPub 2021 Sept 22Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.

PubMed lists: COVE Study Group [Corporate Author]

Wang EW, Parchem JG, Atmar RL, Clark EH.Open Forum Infect Dis.

-GC

Summary

W

A background research post by Gail Combs

PREFACE

by Wolf Moon

The Covid Second Opinion Forum

The Timeline of FDA Decisions

These meetings are AFTER the STOLEN ELECTION but again all three advisory boards are present.

The VRBPAC Advisory Committee

To the Editors:

Vaccine Approval For Children

Jia Huang – Southern University of Science and Technology CHINA and 42 other authors with only 7 others not Chinese. The other universities were Sichuan University, China and Sanford.

Abstract

Current Projects

Papers:

2018

To the Editors:

2013

Williams SE, Rothman RL, Offit PA. Schaffner W, Sullivan M, Edwards KM. A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study. Academic Pediatrics (2013) 13: 475-480.

Summary

-Gail Combs

GC/wm (written/edited)

W

THE LIST OF MANDATE SHAME

Amtrak

Anthem

Apple

Ascension Health

BlackRock

Centene Corporation

Chevron

Cisco

Citigroup

Clayton Homes (Warren Buffett)

CNN

CVS Health

Deloitte

EPub 2021 Sept 22
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.